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One-third of the world’s population is infected with Mycobacterium tuberculosis, which causes 
over 2 million deaths annually. M. tuberculosis typically infects humans through the inhalation 
of aerosolized microorganisms and the host’s immune system controls the infection by 
developing a granuloma, which consists predominantly of macrophages and lymphocytes. The 
factors initiating the formation and maintenance of these granulomas are not well understood, but 
immune cells are likely recruited to the site of inflammation to maintain immune control of the 
infection. Chemokines and cytokines play important roles in cell trafficking and migration of 
immune cells, and DC initiate an adaptive immune response. My hypothesis is that DC (in 
conjunction with macrophages) recruit immune cells to the granulomatous site by the expression 
of IFN-γ-inducible chemokines, which are expressed due to mycobacterial antigen stimulation. 
To determine local cytokine- and chemokine-specific and DC-associated mRNA expression 
patterns in granulomatous lesions, I performed in situ hybridization (ISH) on paraformaldehyde-
fixed, cryopreserved lung tissue sections obtained from cynomolgus macaques (Macaca 
fascicularis) infected with a low dose of virulent M. tuberculosis. In addition, we evaluated the 
presence of mycobacterial 16S rRNA to determine the distribution of the mycobacteria and the 
mycobacterial burden within the granulomas. To model the immune environment in the 
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pulmonary granulomas, I infected human monocyte-derived DC with M. tuberculosis in the 
presence of IFN-γ. Although I found an abundant expression of the IFN-γ-inducible chemokines 
and numerous DC-associated genes within the granulomas, the IFN-γ-inducible chemokine 
expression was predominantly produced by macrophages. The presence of DC in the granuloma 
may serve to skew the immune response to a type I environment, but our data do not suggest a 
direct role in the production of IFN-γ-inducible chemokines. These studies provide further 
information on the potential roles for chemokines and DC in granuloma formation and 
maintenance as well as the composition of local DC populations. These studies further illustrate 
the complex microenvironment of granulomas, which are important in the control of tuberculosis 
infection. Further understanding of granuloma formation and maintenance could lead to the 
development of therapeutic treatments needed to reduce this public health epidemic. 
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I. 
INTRODUCTION 
 
 Tuberculosis (TB) is a life-threatening disease in which one-third of the world’s 
population is currently infected with Mycobacterium tuberculosis and 2.2 million deaths occur 
annually (1). In humans, infection by M. tuberculosis typically occurs by inhalation of 
aerosolized microorganisms into the lungs, which serve as the primary site of infection. M. 
tuberculosis is a slow-growing, acid-fast, rod-shaped bacillus, which preferentially infects 
macrophages and is capable of residing in macrophages in a state that is resistant to immune 
responses. Infected macrophages release cytokines, which increase local inflammation and result 
in the development of a granulomatous lesion (2). This microenvironment within a 
granulomatous lesion restricts the bacterium from dissemination and allows the intimate 
interaction of immune cells and infected macrophages. The acquired immune response and these 
granulomatous structures are an effective prevention of active disease in approximately 90% of 
all M. tuberculosis infections (2,3). 
 
Granulomas: histological characteristic of tuberculosis  
Granulomas are histological hallmarks of several chronic infectious diseases, such as 
tuberculosis, brucellosis, and schistosomiasis, and also develop due to the presence of allergens 
and metals. These granulomatous lesions are generally considered to be the result of chronic 
antigenic stimulation (4,5). The tuberculous granuloma in humans is a focal collection of 
mononuclear cells surrounded by a halo of additional monocytes, lymphocytes and connective 
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 tissue, including fibroblasts, collagen fibers and newly formed vessels (5-9). Granuloma 
formation occurs when an infected macrophage becomes encircled by other macrophages and the 
immune system attempts to wall-off the microorganism to prevent the bacteria from spreading 
locally and throughout the body. The granuloma physically restricts the bacilli and provides an 
environment for immune cells to interact and develop an effective immune response directed 
against the bacilli. This local environment leads to the inhibition of growth or to the death of M. 
tuberculosis due to the production of cytokines, activation of macrophages and cytotoxic killing 
by CD8+ T cells.  
Granulomas are composed mostly of macrophages, CD4+ and CD8+ lymphocytes and B 
lymphocytes (10), but a novel morphological characteristic of the granuloma is the presence of 
epithelioid cells, which are large mononuclear cells with increased cytoplasm and dispersed 
chromatin resembling epithelial cells (5). These epithelioid cells are derived from macrophages 
and their function in the center of the granuloma is suggested to be for secretion of biologically 
active factors. In fact, epithelioid cells have been shown to control the rate of multiplication of 
M. tuberculosis in granulomas in the hamster model (11); Langhans multinucleated giant cells 
can also be found in human and macaque granulomas (5,12). 
Granulomas can exist as a solid mass of cells or can develop necrosis in the central 
portion of the structure. In humans, this necrotic center can develop further into a caseous 
granuloma (13). Currently, a progression model of tuberculous granulomas has not been 
established. Although a caseous granuloma generally is a solid mass, a caseous granuloma can 
undergo liquefaction if the infection is not controlled, and this liquefied milieu supports 
extracellular replication of M. tuberculosis. Some caseous granulomas evolve and develop 
cavities within the lung and have been associated with high bacterial burden (14). As the 
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 granuloma controls infection, fibrosis of the lesion occurs and fibrosis is associated with a 
reduction in the inflammatory process. Characteristics of human granulomas have been observed 
in non-human primate models of tuberculosis (12). 
 
Immune response to Mycobacterium tuberculosis 
Mycobacterium tuberculosis infection induces a proinflammatory immune response, 
characterized by the expression of IFN-γ, TNF-α and IL-12 (3,9,15-21). Although information 
has been obtained from bronchoalveolar lavages (BAL) and lung biopsies during advanced 
disease in humans, only a small number of studies have examined the local cytokine expression 
patterns associated specifically within granulomas. Examination of BAL cells has indicated that 
M. tuberculosis induces a type 1 polarized cytokine response characterized by IFN-γ expression 
(22-25). Barry et al., described strong IFN-γ and TNF-α responses in CD4+ T cells isolated from 
BAL and activated with purified protein derivative (PPD) among patients with TB, while PPD-
activated IFN-γ and TNF-α-producing CD4+ T cells were low among control subjects (22). 
Another study revealed that the peripheral blood and BAL samples from patients with primary 
tuberculosis were characterized by high levels of IL-6 and IFN-γ (23). Robinson et al., 
determined that the increased number of IFN-γ-producing cells in the BAL of tuberculosis 
patients were predominantly T lymphocytes (80% of IFN-γ mRNA-positive BAL cells) rather 
than alveolar macrophages (14.3%). This study also showed that there was not a significant 
difference in the proportion of cells expressing IL-2, IL-4, or IL-5 mRNA, which further 
demonstrated the importance of IFN-γ in the immune response against M. tuberculosis infection. 
Robinson et al., concluded that the activation of Th1-like bronchoalveolar T-lymphocytes, in 
addition to the production of IFN-γ by alveolar macrophages, may contribute to the local cellular 
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 immune response in pulmonary tuberculosis (26). Interestingly, expression patterns of IFN-γ 
relative to IL-4 in pulmonary granulomas from individuals with active tuberculosis were highly 
associated with the type of granuloma formed (27). Granulomas with no caseation expressed 
either IFN-γ mRNA or IFN-γ plus IL-4 mRNA, whereas caseous granulomas expressed little 
IFN-γ or IL-4 mRNA (27). These findings suggest that these cytokines play a role in determining 
granuloma architecture.  
 
α/β and γ/δ TCR+ lymphocytes 
The central components of a protective immune response against M. tuberculosis involve 
the interaction of T cells and infected macrophages. CD4+ T lymphocytes have an essential role 
in the immune response, and are supported by other T cell subtypes, such as CD8+, γδ TCR+ T 
cells and CD1-restricted T cell. Although these cells may have antibacterial mechanisms, such as 
perforin or granulysin, these T cell subsets also secrete type 1 cytokines, most notably IFN-γ (28-
30). The level of involvement that each T cell subtype plays in an individual’s immune response 
may vary, and the ability to study this in an animal model allows us to define further the 
potential of these other T cell subtypes to complement CD4+ T cell function. This 
complementarity of CD4+ T cells is illustrated in MHC Class II and CD4 knock-out mice, which 
produce large amounts of IFN-γ; however, the increased IFN-γ levels alone were still not 
sufficient to control infection (30).  Macrophage activation is triggered by IFN-γ, which is 
augmented by TNF-α, and macrophage activation can lead to production of reactive oxygen 
intermediates (ROI) and reactive nitrogen intermediates (RNI), acidification of phagosomes, 
fusion of phagosomes and lysosomes, and iron restriction to restrict mycobacterial growth (28).  
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 CD4+ and CD8+ T cells recognize antigen in the context of MHC II or I, respectively. 
This recognition is facilitated through the TCR, which is a heterodimeric transmembrane protein 
composed of two chains. The four different TCR polypeptide chains described are T-cell 
receptor α, β, γ and δ chains. Two chains bind together to form a heterodimer through disulfide 
bonds and resemble the immunoglobulin molecule. The predominant T-cell receptor is the α:β 
heterodimer and the αβ TCR is recognized by all functional classes of T cells. The other TCR 
complex that is important in the immune response is the γ:δ heterodimer and γδ TCR+ T cells 
appear to play an important role in the immune response to M. tuberculosis by their ability to 
recognize nontraditional phosphoantigens (28). Ladel et al., found that TCRβ-/- mice succumbed 
to a low dose inoculum of M. tuberculosis, whereas TCRδ-/- mice developed transient disease 
exacerbation (31). The development of granulomas and bacterial containment within these 
granulomas were impaired in TCRβ-/- mice, and the TCRδ-/- mice were less severely affected 
(31). Ladel et al., further validated the function of αβ TCR+ T cells in protection against 
tuberculosis infection and established a novel protective role of TCRγδ T cells in early stage of 
tuberculosis (31). 
 
Experimental animal models 
 Animal models have further defined the general mechanisms underlying natural 
resistance and the acquisition of a protective immune response against M. tuberculosis, in 
addition to increasing our understanding of the pathology of tuberculosis. The most commonly 
used animal models for tuberculosis are the guinea pig, rabbit, mouse and non-human primate. 
The genetic manipulation and availability of immunologic reagents in mice has allowed 
researchers to study the role of distinct cells and surface molecules in an in vivo system.  Many 
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 initial observations in mice have been confirmed in humans, including the importance of IFN-
γ, TNF-α and CD4+ T cells in the control of M. tuberculosis [reviewed in (28)]. Unfortunately, 
the mouse model does not include the development of caseous granulomas consistent with 
pathology observed in humans, and cell types have slightly different specificities, e.g., γδ T cells 
(32). The most notable animal model for tuberculosis is the non-human primate. This model 
develops a slowly progressing disease with a lower percentage of animals developing primary 
disease and likely controlling the infection prior to a reactivation state The stages of disease 
closely resemble the course of infection in humans and histologically the granulomas appear 
strikingly similar (12). The negative aspect of this model is the cost of primates and necessity for 
more sophisticated containment precautions. 
Another model of tuberculosis that demonstrated the full spectrum of disease seen in 
immunocompetent humans is the rabbit model. Rabbits also have a natural resistance to 
infection, and manifest pulmonary cavitary lesions during the course of progressive disease (14). 
Finally, guinea pigs have also been used as a model of tuberculosis due to the development of 
granulomatous lesions very similar to those observed in human tuberculosis patients. The use of 
guinea pigs is especially important when examining CD1-restricted lymphocytes, cells that 
recognize mycobacterial glycolipids, since these cells are found in humans and guinea pigs, but 
not in mice (33). In conclusion, there are several model systems in addition to the cell culture 
systems that have advanced the understanding of the immune response and pathogenesis of 
tuberculosis.  
 
Recruitment of immune cells by chemokines 
Granuloma formation likely requires the recruitment of cells to the site of inflammation 
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 via the expression of chemotactic molecules, and prior to our publication of data from this 
dissertation only one study had examined chemokine expression directly in granulomatous tissue 
sections (34). Chemokines are approximately 8 to 10 kDa secreted proteins with chemotactic 
activity and play a major role in the recruitment of receptor-bearing cells to sites of inflammation 
(35,36). Chemokines are a family of small cytokines with four conserved cysteine residues 
linked by disulfide bonds (35). These chemokines are categorized into four families based on 
number of amino acids separating the cysteine residues in the amino acid sequence. The 
functions of chemokines include chemotaxis, integrin activation and degranulation of distinct 
leukocyte subsets expressing specific chemokine receptors (37). The expression of chemokines is 
controlled by local environmental signals, such as TNF-α or IFN-γ (35,38). Whereas the CC 
chemokines recruit lymphocytes, monocytes, basophils and eosinophils, suggesting a less 
selective recruiting process, the ELR+ (Glutamic acid-Leucine-Arginine) CXC chemokines are 
potent recruiters of neutrophils and ELR- CXC chemokines selectively recruit lymphocytes (35). 
 Granulomas induced experimentally in mice with mycobacterial antigen-coated beads 
lead to the development of type 1 cytokine and chemokine expression profiles (15,16,19). IFN-γ 
induces macrophages and DC to produce IFN-γ-inducible, CXCR3 ligands, CXCL9/monokine 
induced by γ-interferon (Mig), CXCL10/γ-interferon-inducible protein (IP-10), and 
CXCL11/IFN-inducible T-cell α-chemoattractant (I-TAC), which recruit CXCR3+ cells (39). 
CXCR3 is a G-protein-coupled receptor that is expressed on memory and activated CD4 and 
CD8 lymphocytes, B cells and NK cells (40). Interestingly, CXCR3+ cells characteristically 
express type 1 cytokines (41), and therefore, can potentially induce further upregulation of 
CXCR3 ligands, leading to chronic type 1 polarized inflammation. 
 
 
 
7
 Table 1. Chemokines examined in these studies 
 
 Systemic SCY Human  
Family Name Name Ligand Receptor 
 
 
CXC CXCL9 SCYB9 Mig CXCR3 
 CXCL10 SCYB10 IP-10 CXCR3 
 CXCL11 SCYB11 I-TAC CXCR3 
 
 
CC  CCL2 SCYA2 MCP-1 CCR2 
 CCL3 SCYA3 MIP-1α CCR1, CCR5 
 CCL4 SCYA4 MIP-1β CCR5 
 CCL5 SCYA5 RANTES CCR1, CCR3, CCR5 
 
 
Murine gene disruption and in vivo neutralization studies have shown the importance of 
recruitment of infiltrating CXCR3-bearing cells via CXCR3 receptor:ligand interactions. In vivo 
neutralization of CXCL9/Mig and CXCL11/IP-10 in mice reduced recruitment of the CXCR3+ 
cells, but the disruption of the CXCR3 gene drastically disrupted this recruitment mechanism via 
its ligands and thus reduced the severity of idiopathic pneumonia syndrome (42) or prolonged 
functional graft survival (43). Recruitment of CXCR3+ T cells by CXCL10/IP-10 have been 
implicated in allograft rejection (44). Interestingly, CXCR3-/- mice have been used to examine 
the role CXCR3 in fibroproliferation. Jiang et al., showed that CXCR3-deficient mice had 
increased fibrosis without increased recruitment, reduced early burst of IFN-γ and decreased 
expression of CXCL10/IP-10 (45). In the context of tuberculosis CXCR3-/- mice and anti-
CXCL9/Mig-treated mice developed pulmonary granulomas, but the relative size of the 
granulomas were reduced 4.5- and 2-fold, respectively. Interestingly this same study showed that 
there was no difference in the survival or the mycobacterial load when comparing CXCR3-/- and 
anti-CXCL9/Mig-treated mice to wild-type controls (46). 
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 Upregulated chemokines are likely produced by multiple cell types at the site of 
inflammation, especially by antigen presenting cells (APC). Macrophages have been shown to 
produce CXCR3 ligands in response to IFN-γ and M. tuberculosis infection alone (47), and DC 
also have been shown to produce IFN-γ-inducible chemokines during M. tuberculosis infection 
(48). DC are crucial to the induction of an adaptive immune response in M. tuberculosis 
infection and DC, in addition to macrophages, may potentially be responsible for the production 
of CXCR3 ligands at the site of the granuloma due to IFN-γ and or M. tuberculosis infection 
alone. The APC in the lung are typically submucosal and interstitial DC, and alveolar 
macrophages (49,50). Macrophages and DC perform surveillance functions within the 
pulmonary cavity, and DC, not macrophages, migrate to the regional lymph node based on a 
chemotactic gradient and adhesion molecules, leading to the priming of naïve T-lymphocytes 
(51,52). In addition, DC play a role in bridging the gap between the innate and adaptive immune 
response by recognizing pathogens and inducing a protective immune response. DC have been 
shown to bind M. tuberculosis via the DC-SIGN (dendritic cell-specific intercellular adhesion 
molecule 3-grabbing nonintegrin) molecule (53), thus, DC are also a target for M. tuberculosis 
infection and potentially aid in dissemination of the mycobacteria during migration.  
Recent studies have shown the presence of DC in the granulomatous lesion of an 
experimental or spontaneous infection using immunohistochemical staining of DC-associated 
markers (54-56). In human tuberculosis patients, the numbers of peripheral blood CD11c+ DC 
were lower than in control patients and CD11c+ DC infiltrated the lymphocyte areas of the 
granulomatous lesion (56), suggesting the migration of DC from the peripheral blood to the 
inflammatory site. Other studies have utilized rodent animal models to assess the DC role in the 
immune response to mycobacterial infection. Tsuchiya et al., demonstrated in a rat model with 
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 bacillus Calmette-Guerin (BCG)-elicited pulmonary granulomas that DC were present at the site 
of the granulomatous lesion and these isolated DC had an effective ability to stimulate allogeneic 
T-lymphocytes (55). Thus, the DC likely may participate in the formation of granulomas based 
on their potent antigen presentation abilities. 
In addition, DC were shown to play a key role in initiating granulomatous cell-meditated 
immunity in mice infected with purified protein derivative (PPD)-coated beads (54). The 
CD11c+ DC in all granulomas were in contact with the beads and DC expressed IL-12p40 
mRNA as determined by ISH. In addition, when isolated on day 1 these DC stimulated PPD-
specific T-lymphocyte proliferation (54). The migration of these DC to regional lymph nodes is  
a dynamic process that involves the maturation of the DC from an immature to a mature DC, 
which includes the upregulation of costimulatory molecules and chemokine receptors, 
specifically CCR7 (57). The migration to the regional lymph node is facilitated by the expression 
of CCR7 chemokines, CCL19/MIP3-β and CCL21/6Ckine. Interestingly, in the granulomatous 
lesions of giant cell arteritis, mature DC expressing CCR7 are maintained within the granuloma 
likely due to the overexpression of CCL19/MIP3-β and CCL21/6Ckine (58). It is not clear 
whether the DC present in the tuberculous granulomas are maintained at the site by the CCR7 
chemokines or are continuously recruited by other potential mechanisms. 
In summary, the local chemokine expression patterns in granulomatous tissues have not 
been fully examined in tissue sections directly and the DC populations present at the site of the 
granuloma are not well characterized. Experimental M. tuberculosis infection in a macaque 
model induces granuloma formation remarkably similar to that seen in humans infected with this 
pathogen (12,59). Here, I have established that the chemokine and cytokine mRNA expression 
patterns in lung tissues from M. tuberculosis-infected cynomolgus macaques (Macaca 
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 fascicularis) were abundant as determined by in situ hybridization (ISH). In addition, I have 
determined that these IFN-γ-inducible chemokine mRNAs were predominantly expressed by 
macrophages by simultaneous ISH and IHC; DC also expressed some of these chemokines. 
Additionally, I characterized the DC populations within granulomatous lesions to find a large 
number of DC-associated genes expressed in the granulomatous lesion. Finally, I examined the 
mycobacterial burden within the granulomatous tissues to potentially clarify whether the 
abundant expression of IFN-γ-inducible chemokines is likely a function of immune dysregulation 
or of continuous antigenic stimulation. Altogether, these data reveal the presence of DC and an 
abundant expression of several recruitment molecules and proinflammatory molecules known to 
drive immune responses. These findings are important, because previous studies have shown the 
upregulation of certain cytokines, but have not shown that the source of IFN-γ-inducible 
chemokines is within the granulomatous structure itself. These findings altogether have further 
defined the granuloma microenvironment in an attempt to understand how a granuloma is 
maintained, whereas further studies must be performed to explain the formation of tuberculous 
granulomas. 
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II. 
SPECIFIC AIMS 
 
 Tuberculosis is a global epidemic, which is exacerbated by the breakdown of health 
services, the emergence of multi-drug resistant TB, and the global spread of HIV/AIDS. 
Mycobacterium tuberculosis infects humans through the inhalation of aerosolized 
microorganisms and primarily targets the pulmonary compartment. In an immunocompetent 
individual, the host’s immune system controls the infection by surrounding the mycobacteria in a 
structure called a granuloma, a histological hallmark of tuberculosis. The factors initiating the 
formation of these granulomas are not well understood. However, granulomas characteristically 
are composed primarily of macrophages and lymphocytes, which are potentially recruited to the 
site of inflammation to prevent the dissemination of the microorganism. Chemokines and 
cytokines play important roles in the recruitment of immune cells, and our hypothesis is that 
DC (in conjunction with macrophages) recruit immune cells to the granulomatous site by 
the expression of proinflammatory cytokines and the IFN-γ-inducible chemokines, which 
are expressed due to their exposure to mycobacterial antigens. Since tuberculosis is a disease 
characterized by a type 1 polarized immune response, specifically IFN-γ and TNF-α, we 
examined the expression levels and patterns of the IFN-γ-inducible chemokines and 
proinflammatory cytokines and characterized the DC populations within the granulomatous 
lesions. These studies were performed using a nonhuman primate model infected with a low dose 
of M. tuberculosis and performing single-cell based and in vitro assays on cynomolgus macaque 
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 tissues and peripheral blood cells. These studies have provided novel information on the local 
chemokine expression patterns and the expression patterns of DC-associated genes. 
 
The overall aim of this project was to understand further the development/maintenance of 
granulomatous structures in cynomolgus macaques infected with M. tuberculosis. My specific 
aims to achieve this goal are listed below. 
 
Specific Aim 1. Determine the local expression of IFN-γ-inducible chemokine and 
proinflammatory cytokine mRNAs in pulmonary granulomatous tissue sections of 
cynomolgus macaques (Macaca fascicularis) experimentally infected with a low dose of 
Mycobacterium tuberculosis Erdman strain. Since tuberculosis is characterized by a polarized 
IFN-γ and TNF-α expression profile, I examined the expression levels of recruitment molecules 
directly induced by IFN-γ, the IFN-γ-inducible chemokines. To achieve this, I studied 
cynomolgus macaques that were infected with a low dose of M. tuberculosis Erdman strain via 
bronchoscope and sacrificed at various states of disease. These resources were available through 
a collaborative study with Dr. JoAnne L. Flynn. I used in situ hybridization (ISH) to examine 
paraformaldehyde-fixed, cryopreserved lung tissues for chemokine and cytokine mRNA 
expression patterns, which were quantified by quantitative image analysis (QIA). In addition, I 
determined which cells are expressing the chemokine/cytokine mRNAs by performing 
simultaneous in situ hybridization and immunohistochemistry. 
 
Specific Aim 2. Characterize the dendritic cell population in the pulmonary granulomatous 
tissue sections of cynomolgus macaques experimentally infected with Mycobacterium 
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 tuberculosis. DC serve a major function in the development of an appropriate adaptive immune 
response and DC have been described in granulomatous lesions, through the application of a 
small number of antigenic markers. Therefore, I sought to further characterize the DC 
populations in granulomatous lesions. Using paraformaldehyde-fixed, cryopreserved lung tissues 
harvested at necropsy, we characterized the DC populations in the granulomatous lesions using 
ISH with eight DC-associated riboprobes. The specific genes selected to characterize the type of 
DC are CD11c, CD123, DC-SIGN, DC-LAMP, B7-DC, DC-STAMP, CCR6 and CCR7.  
 
Specific Aim 3. Determine whether mycobacterial antigen can stimulate the expression of 
inflammatory chemokines in dendritic cells. Tuberculosis is characterized by an abundant type 
1 immune response, which is stimulated by the mycobacterial antigens, and we sought to 
examine the direct association between mycobacterial antigen and the IFN-γ-inducible 
chemokines in situ and in vitro. Using paraformaldehyde-fixed, cryopreserved lung tissues 
harvested at necropsy, we examined the lung tissues for mycobacterial 16S rRNA associated 
with granulomatous lesions by ISH. The intensity and distribution of ISH signal were examined 
and correlated with the chemokine and cytokine expression patterns. In addition, monocyte-
derived DC were infected with M. tuberculosis in the presence and absence of IFN-γ and the 
IFN-γ-inducible chemokine mRNA expression levels were analyzed by real-time RT-PCR. 
 
Collectively, these studies executed under these aims provided further insight into the 
maintenance of the granulomatous lesion and provide further insight into how DC might affect 
the granuloma by their presence. Whereas the field is aware of the macrophage’s role in the 
immune response and ability to control the mycobacteria, the role of the DC within the 
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 granuloma is not fully understood. We sought to further define the DC populations in the 
granulomatous lesion by using these DC-associated markers. We have shown in these studies 
that the expression of IFN-γ-inducible chemokines is abundant at the site of the granuloma and 
that these chemokines are expressed predominantly by macrophage and not by DC. We also have 
shown a potential marker for IL-4 expression, DC-STAMP. The development of the granuloma 
is still not well understood, but these studies show a consistent pattern of chemokine expression 
illustrating a potential coordination of the maintenance of a granuloma structure. 
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III. 
IN SITU STUDY OF ABUNDANT EXPRESSION OF PROINFLAMMATORY 
CHEMOKINES AND CYTOKINES IN PULMONARY GRANULOMAS THAT 
DEVELOP IN CYNOMOLGUS MACAQUES EXPERIMENTALLY INFECTED WITH 
MYCOBACTERIUM TUBERCULOSIS 
 
(Published 2003 Infection and Immunity Volume 71:7023-7034  (60)) 
 
This chapter includes a manuscript published in Infection and Immunity in its entirety with 
permission from American Society for Microbiology. Additional studies were performed to 
address questions not included in the final manuscript. These sections are presented at the end of 
the Results section under the following sections: 
Expression of IFN-γ in the lymphocyte population 
Characterization of the expression and distribution of T Cell receptor chains in 
granulomas from cynomolgus macaques 
 ISH analyses in hilar lymph node 5 weeks post-infection  
Expression of CCR5 ligands in granulomas from cynomolgus macaques  
All of the tissue-based studies were performed by Craig Fuller, while all of the animal care needs 
and medical services were performed by the staff in Dr. JoAnne Flynn’s laboratory and by the 
Division of Laboratory Animal Resources (DLAR). 
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 A. PREFACE 
 
In this section I have described published data related to IFN-γ-inducible chemokines and 
proinflammatory cytokines observed in pulmonary granulomas in cynomolgus macaques 
infected with M. tuberculosis. This chapter contains data from ISHs for IFN-γ-inducible 
chemokine and proinflammatory mRNAs, which was abundant in both solid and caseous 
granulomas.  I revealed in these studies that CXCL9/Mig mRNA was the most abundant by 
quantitative image analysis and the CXCR3 ligand mRNA expression correlated with an 
increased observation of CXCR3+ cells within the granuloma, as compared to normal lung 
tissues.  I also observed an increased expression of IFN-γ and TNF-α mRNAs associated with 
granulomatous tissues, compared to uninfected lung tissues. In addition, I developed an ISH 
assay for mycobacterial 16S rRNA to overcome limitations observed in formalin-fixed tissues. 
Using this ISH assay, I observed mycobacterial 16S rRNA within the acellular portions of 
caseous granulomas. Altogether, these studies provided further information on the expression of 
IFN-γ-inducible chemokine, IFN-γ and TNF-α mRNAs and cell populations directly within the 
granulomatous structure. These studies suggest that CXCR3 ligands likely play a role in the 
recruitment of CXCR3-bearing cells to the site of the granuloma. 
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 B. ABSTRACT 
 
Tuberculosis remains a major public health problem worldwide. Chemokines and cytokines 
organize and direct infiltrating cells to sites of infection, and these molecules likely play crucial 
roles in granuloma formation and maintenance. To address this issue, we used in situ 
hybridization (ISH) to measure chemokine and cytokine mRNA expression levels and patterns 
directly in lung tissues from cynomolgus macaques (Macaca fascicularis) experimentally 
infected with a low dose of virulent M. tuberculosis. We examined more than 300 granulomas 
and observed abundant expression of IFN-γ-inducible chemokine mRNAs (CXCL9/Mig, 
CXCL10/IP-10, and CXCL11/I-TAC) within solid and caseous granulomas, with only minimal 
expression in nongranulomatous regions of tissue. The mRNA expression patterns of IFN-γ and 
TNF-α were examined in parallel and revealed that cytokine mRNA+ cells were abundant and 
generally localized to the granulomas. Mycobacterial 16S rRNA expression was also measured 
by ISH and revealed localization predominantly to the granulomas with the highest signal 
intensity in caseous granulomas. We observed several granulomatous lesions with exceptionally 
high levels of RNA for mycobacterial 16S rRNA, IFN-γ, and IFN-γ-inducible chemokines 
suggesting that the local presence of mycobacteria is partly responsible for the upregulation of 
IFN-γ-inducible chemokines and recruitment of CXCR3+ cells, which were also abundant in 
granulomatous lesions. These studies suggest that expression of CXCR3 ligands and the 
subsequent recruitment of CXCR3+ cells are involved in granuloma formation and maintenance.                       
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 C. INTRODUCTION 
 
Tuberculosis (TB) is a global public health epidemic in which 2 billion people are currently 
infected with Mycobacterium tuberculosis and 2.2 million deaths occur annually (1). Infection by 
M. tuberculosis typically occurs by inhalation of aerosolized microorganisms into the lungs, 
which serve as the primary site of infection. A granulomatous lesion develops to contain the 
bacteria, which is effective given that 90% of all M. tuberculosis infections do not result in active 
disease (2,3). M. tuberculosis preferentially infects macrophages and appears to be capable of 
residing in macrophages in a state that is resistant to immune responses. Infected macrophages 
release cytokines, which increase local inflammation and result in the development of the 
granulomatous lesion (2). 
Granulomas are hallmarks of chronic infectious diseases, such as tuberculosis, 
brucellosis, and schistosomiasis, and also develop due to the presence of allergens and metals. 
These granulomatous lesions are generally considered to be the result of chronic antigenic 
stimulation (4,5). The tuberculous granuloma is a focal collection of mononuclear cells 
surrounded by a halo of lymphocytes and additional monocytes (5-9). This reaction occurs when 
an infected macrophage becomes encircled by other macrophages and the immune system 
attempts to wall-off the microorganism to prevent the bacteria from spreading locally and 
throughout the body. This complex cellular structure can be surrounded by connective tissue, 
including fibroblasts, collagen fibers and newly formed vessels (5). A novel morphological 
characteristic of the granuloma is the presence of epithelioid cells, which occupy the center of 
the lesion. These epithelioid cells are activated macrophages, which have increased cytoplasm 
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 and disperse chromatin resembling epithelial cells (5).  Langhans multinucleated giant cells are 
also be found in granulomas. 
M. tuberculosis induces a proinflammatory immune response, characterized by the 
expression of IFN-γ, TNF-α and IL-12 (3,9,15-18,21,61,62). Although information has been 
obtained from bronchoalveolar lavages (BAL) and lung biopsies during advanced disease in 
humans, only a small number of studies have examined the local cytokine expression patterns 
associated specifically with granulomas. Examination of BAL cells has indicated that M. 
tuberculosis induces a type 1 polarized cytokine response characterized by IFN-γ expression (22-
24,63). However, when Fenhalls et al. studied pulmonary granulomas from individuals with 
active tuberculosis, they found that the expression patterns of IFN-γ relative to IL-4 were highly 
associated with the type of granuloma formed (64). Granulomas with no evidence of caseation 
expressed either IFN-γ mRNA or IFN-γ plus IL-4 mRNA, whereas caseous granulomas 
expressed little IFN-γ or IL-4 mRNA (65). These findings suggest that these cytokines play a 
role in determining granuloma architecture.  
The development of a granuloma likely depends on the movement of cells toward the site 
of inflammation due to expression of chemotactic molecules, although only one study to date has 
examined local chemokine expression directly in granulomatous tissue sections (34). 
Proinflammatory chemokines are chemotactic cytokines, which play a major role in the 
recruitment of receptor-bearing cells to sites of inflammation (35,36). The functions of 
chemokines include chemotaxis, integrin activation and degranulation of distinct leukocyte 
subsets expressing specific chemokine receptors (66). The expression of proinflammatory 
chemokines is induced by local environmental signals, such as TNF-α or IFN-γ (35,38). 
Granulomas induced experimentally with mycobacterial agents lead to the development of type 1 
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 cytokine and chemokine expression profiles (15,16,67). IFN-γ induces macrophages and 
dendritic cells (DC) to produce IFN-γ-inducible, CXCR3 ligands, CXCL9/monokine induced by 
γ-interferon (Mig), CXCL10/γ-interferon-inducible protein (IP-10), and CXCL11/IFN-inducible 
T-cell α-chemoattractant (I-TAC), which recruit CXCR3+ cells (39). CXCR3+ cells typically 
express type 1 cytokines (41), and therefore, can potentially induce further upregulation of 
CXCR3 ligands, leading to chronic type 1 polarized inflammation, as we have proposed occurs 
during simian immunodeficiency virus (SIV) infection of rhesus macaques (Macaca mulatta) 
(68). 
The local chemokine expression patterns in granulomatous tissues have not been fully 
examined directly in tissue sections thus far. Experimental M. tuberculosis infection in a 
macaque model induces granuloma formation remarkably similar to that seen in humans infected 
with this pathogen (59,69,70). In this report, we have examined the chemokine and cytokine 
mRNA expression patterns in lung tissues from M. tuberculosis-infected cynomolgus macaques 
(Macaca fascicularis) by in situ hybridization (ISH). These studies provide direct evidence that 
IFN-γ mRNA is present and abundant in the granulomas of infected cynomolgus macaques, and 
that IFN-γ-inducible chemokine mRNAs are upregulated and potentially responsible for the 
recruitment of CXCR3+ cells that could further skew the immune environment through ongoing 
IFN-γ production. The abundant expression of IFN-γ-inducible, CXCR3 ligands and 
inflammatory cytokines IFN-γ and TNF-α directly within solid and caseous granulomas suggests 
that continual cell recruitment and a state of chronic inflammation likely contribute to the 
formation and maintenance of tuberculous granulomas. 
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 D. MATERIALS AND METHODS 
 
Animals and tissue processing 
All animal studies were performed under the guidance and approval of the University of 
Pittsburgh Institutional Animal Care and Use Committee. Nine adult cynomolgus macaques were 
inoculated with a low dose (approximately 25 colony forming units) of virulent M. tuberculosis 
(Erdman strain) via bronchoscope into the lower right lobe, as described elsewhere (70). 
Infection was allowed to proceed until macaques reached disease states that spanned a spectrum 
from no apparent disease to advanced disease. At necropsy, tissues were collected and fixed in 
4% paraformaldehyde/1X phosphate buffered saline (PF/PBS) for 5 hr at 40oC, as previously 
described (71). After fixation, the tissues were cryoprotected and snap frozen in isopentane 
cooled on dry ice to -65oC. 
 
Immunohistochemistry 
Immunohistochemical staining of 14µm tissue sections was performed using cell-type specific 
antibodies: anti-CD3 (clone CD3-12, NovoCastra), anti-CD68 (clone KP1, Dako), anti-CD20 
(clone L26, Dako) and anti-CXCR3 (clone 1C6, Pharmingen). Tissue sections were pretreated in 
0.01M sodium citrate (pH 6.0) by microwaving followed by application of the primary antibody 
(diluted in 1X PBS) to the tissues for 1 hr in a humid chamber at room temperature. Primary 
antibodies were detected with the PicTureTM-Plus detection system (Zymed Laboratories), using 
3,3’-diaminobenzidine as the final substrate.  
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 In situ hybridization (ISH) 
Riboprobe syntheses and ISHs were performed on 14µm tissue sections as previously described 
(68,71,72). Cytokine and chemokine mRNAs were detected by ISH using gene-specific 
riboprobes. Plasmids containing macaque IFN-γ and TNF-α cDNAs were kindly provided by 
Francois Villinger (Emory University). Plasmids encoding CXCL9/Mig, CXCL10/IP-10 and 
CXCL11/I-TAC genes were previously described (68,73). Autoradiographic exposure times 
were 7, 10 and 11 days for chemokine and cytokine mRNA and M. tuberculosis 16S rRNA ISHs, 
respectively.  
 
Quantitative image capture and analysis  
Each granuloma present in lung tissue sections was categorized as a solid or caseous granuloma. 
ISH signal intensities were measured by quantitative image analysis. Using a RT Slider Spot 
camera (Diagnostic Instruments, Inc.), we captured images of all granulomas using a 4X 
objective lens. The MetaView software package (Universal Imaging Corp.) was used to measure 
the surface area covered by autoradiographic silver grains, as well as the total surface area of the 
granuloma. After color separation, the green channel was converted to pseudocolor and the 
image was thresholded to measure the surface area covered by silver grains.  
 
M. tuberculosis 16S rRNA subcloning, sequencing 
The 16S rDNA from M. tuberculosis strain H37Rv was amplified by PCR using sequence 
specific forward (5’-GGCGTGCTTAACACATGCAA-3’) and reverse (5’-
CGCTCACAGTTAAGCCGT-3’) primers, as previously described (74). The amplified product 
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 (550 bp) was subcloned into pGEMT and DNA sequenced, which revealed 100% homology to 
16S rRNA genes of both H37Rv and CDC1551 strains of M. tuberculosis (data not shown).  
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 E. RESULTS 
  
Classic granulomatous lesions arise in macaque pulmonary tissues 
To address key issues regarding granuloma formation and maintenance in a nonhuman 
primate model, cynomolgus macaques were inoculated intrabronchially with a low dose of 
virulent M. tuberculosis (Erdman strain).  All nine animals examined in this study were 
successfully infected as demonstrated by tuberculin skin test, PBMC lymphoproliferative 
response to mycobacterial antigens, positive bacterial cultures from BAL and by radiographic 
observations. Detailed clinicopathological and bacteriological findings are being presented 
separately (70). These animals varied in their rates and extents of disease progression, but all had 
macroscopic (gross) lesions within lung tissues at necropsy. They were classified as exhibiting 
minimal/moderate disease or advanced disease based upon their clinical condition, and gross and 
microscopic pathological findings.  The pulmonary granulomas detected in these tissue sections 
varied in size and structure (Table 2). We examined more than 300 granulomas in 7 of the 9 
animals, with 93% of the granulomas observed in animals with advanced disease (Table 2). The 
surface areas of the granulomas in 14µm tissue sections ranged from 1.5 x 104 to 5.5 x 106 µm2, 
and approximately two-thirds of the granulomas were caseous. If macaque M15300, which 
harbored the majority of the granulomas examined, was removed from the summary, the mean 
surface areas for solid and caseous granulomas were 1.4 x105 and 7.1 x 105 µm2, respectively, 
and 37% of the granulomas were caseous. Caseous granulomas were present in all animals with 
granulomas, but the majority was observed in the macaques with advanced disease. Solid 
granulomas were present more frequently than caseous granulomas in animals with 
minimal/moderate disease. However,  
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Table 2. Animals and clinicopathological findings. 
 
              Duration of     Radiographic                  Granulomas    
Animal Infection  (wpi)  Readingsa Disease Course Totale Solid Necrotic    Sizef             
M7100 9b + moderate disease 2 0 2 424,136 – 1,820,000 
M15300 10c +++ advanced disease 233 56 177 16,836 – 5,486,090 
M15000 16b ++ moderate disease 13 12 1 20,185 –    996,507 
M14600 17b - no diseased 0  
M15100 17b + moderate disease 7 6 1 33,606 – 1,020,000 
M11301 32c +++ advanced disease 15 9 6 40,992 – 1,250,000 
M11201 37c +++ advanced disease 24 12 12 28,620 – 2,327,970 
M7200 41c +++ advanced disease 7 4 3 14,882 – 2,060,000 
M15200 64b  - minimal disease 0 
 
aRadiographic readings at necropsy. M14600 is the only macaque to not have a positive radiographic reading. However, viable M. tuberculosis 
bacilli could be cultured from lung homogenates at necropsy 
bSacrificed at a scheduled timepoint. 
cSacrificed due to extreme clinical symptoms. 
dOnly a few macroscopic granulomas were observed at necropsy. 
eNumber of granulomas examined in tissues. 
fSurface area in 14µm tissue sections (µm2) 
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 animals with advanced disease harbored more granulomas, and therefore, the majority of the 
solid granulomas were observed in these macaques.  
The cellular compositions of these granulomatous structures were examined by 
immunohistochemical staining (IHC) of formalin-fixed, cryopreserved tissue sections. Both solid 
and caseous granulomas were predominantly comprised of macrophages (CD68+) and 
lymphocytes (Fig. 1). Lymphocytes were mainly T-lymphocytes (CD3+), but B-lymphocytes 
(CD20+) were also detected in the granulomatous lesions as a mixed population of diffusely and 
intensely staining cells (Fig. 1G,H). Regardless of disease state, the compositions of the 
numerous granulomas were similar in all macaques. CD68+ cells (Fig. 1C-D) were more 
abundant than the other cell types examined and the staining pattern was distributed throughout 
the cellular portions of the lesions. The T-lymphocytes (CD3+, Fig. 1E-F) were dispersed 
throughout the cellular portions of the granulomatous lesions, whereas the rare B-lymphocytes 
(CD20+, Fig. 1G,H) were not within a particular location, but were localized in peripheral focal 
collections in caseous granulomas.  The CD4+:CD8+ ratio of T-lymphocytes for a small number 
of disaggregated granulomas from five animals ranged from 0.37 to 1.11 with a mean of 0.68.  
Taken together, these data indicate that cynomolgus macaques inoculated intratracheally with a 
low dose of virulent M. tuberculosis develop classic granulomas.   
 
Abundant expression of IFN-γ-inducible CXCR3 ligands in granulomatous lesions 
Chemokines likely play multiple roles in M. tuberculosis-associated granuloma formation 
and maintenance, including the shaping of the local immune environment. Given that IFN-γ is a 
cytokine critical to host resistance to M. tuberculosis disease progression in mice and humans 
(75-78), we determined the patterns and levels of expression of mRNAs encoding the  
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Figure 1. Structures and cellular compositions of lung granulomas of cynomolgus macaques 
experimentally infected with M. tuberculosis. Each granuloma in lung tissue sections was 
categorized as solid (e.g., M11201, A,C,E,G,I) or caseous (e.g., M11301, B,D,F,H,J). The open 
box in (A,B) identifies the region of the granuloma on subjacent sections, which are presented in 
(C-J), and the necrotic portions of the granulomas are also noted (n).  Specific cell types were 
identified by IHC using antibodies directed against CD68 (C,D), CD3 (E,F), CD20 (arrow, G,H) 
and CXCR3 (arrow, I,J). CXCR3+ cells were also detected as an indirect measure of the 
recruitment of CXCR3+ cells to the granuloma (I,J). The necrotic portions of the granulomas are 
in the top left and bottom right corners of the micrographs (D,F,H,J). Parallel analysis with 
isotype control antibodies yielded no IHC signal (inset, C,D). Original magnification, 100X (A-
B), 200X (C-J). 
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 IFN-γ-inducible chemokines, CXCL9/Mig, CXCL10/IP-10 and CXCL11/I-TAC, directly in lung 
tissues from experimentally infected macaques. This approach can reveal changes in mRNA 
expression levels that might not be as evident using RNAs from homogenized tissues in 
population analyses. ISH for these CXCR3 ligand mRNAs revealed extremely abundant 
expression within the granulomatous lesions, with the highest signal observed for CXCL9/Mig 
and the lowest for CXCL11/I-TAC in both solid and caseous granulomas (Fig. 2). In contrast, 
nongranulomatous regions of lung tissue and lung tissue from M. tuberculosis-naïve control 
macaques rarely exhibited appreciable expression of any CXCR3 ligand mRNA (Fig. 2, data not 
shown). Solid granulomas had intense ISH signal concentrated only over the central portion of 
the granuloma, whereas caseous granulomas had intense ISH signal concentrated over the 
cellular portions of the granulomas surrounding the acellular centers (Fig. 2).  
To provide a measure of mRNA expression, we performed quantitiative image analysis 
of the tissue sections using the MetaView software package. We measured the total surface area 
of each granuloma, as well as the proportion of the cellular surface area covered by 
autoradiographic silver grains. Acellular, necrotic regions were excluded from these calculations. 
As expected, the amount of thresholded surface area attributed to silver grains increased as the 
total surface area of the granuloma increased in both solid and caseous granulomas (data not 
shown). We then determined the percentage of cellular surface area covered by ISH signal (Fig. 
3). The percent thresholded surface area measured over cellular portions of granulomas for 
CXCL9/Mig ISH signal was the highest of the three CXCR3 ligand mRNAs with mean 
percentages of thresholded area of 48% and 51% for solid and caseous granulomas, respectively 
(Table 3). The mean percentages of thresholded surface area for CXCL9/Mig, CXCL10/IP-10           
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Figure 2. In situ hybridization detection of IFN-γ-inducible chemokine and cytokine mRNAs in 
granulomatous lung tissues from M. tuberculosis-infected cynomolgus macaques. ISH was 
performed on lung tissue sections with IFN-γ-inducible chemokine- and cytokine-specific 
riboprobes and representative fields from subjacent sections are presented. A low magnification 
micrograph of the ISH for CXCL9/Mig is shown to highlight the granulomatous tissue (A,B) and 
the open box demarcates the granulomatous region further presented in the remaining 
micrographs (C-L). ISH was performed for CXCL9/Mig (C,D), CXCL10/IP-10 (E,F) and 
CXCL11/I-TAC (G,H) mRNAs in solid (C,E,G) and caseous  (D,F,H) granulomas. IFN-γ (I,J) 
and TNF-α (K,L) mRNAs were detected by ISH in solid (I,K) and caseous (J,L) granulomatous 
lesions. The necrotic portion of the granuloma is in the top left corner of the micrographs 
(D,F,H,J,L). Parallel hybridizations with control sense riboprobes provided no autoradiographic 
signal (inset, C,D). Original magnifications, 20X (A,B), 100X (C-H), 200X (I-L). 
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  and CXCL11/I-TAC in the granulomas from animals with advanced disease were approximately 
two-fold higher than the animals with minimal/moderate disease (Fig. 3, Table 3). In summary, 
IFN-γ-inducible chemokines were dramatically upregulated in macaque pulmonary 
granulomatous lesions relative to nongranulomatous tissue and naïve controls. 
The high levels of expression of CXCR3 ligands would be expected to lead to 
recruitment of CXCR3+ cells into the local environment. To identify CXCR3+ cells, we 
performed IHC using an anti-CXCR3 monoclonal antibody (Fig. 1I,J). CXCR3+ cells were more 
abundant in granulomatous regions compared to nongranulomatous regions of macaque lung 
tissues. The distribution of CXCR3+ cells was not concentrated uniquely in specific areas of the 
granulomatous lesions, but was generally well localized with the expression of the CXCR3 
ligand mRNAs. The increased abundance of these receptor-bearing cells in the granulomatous 
lesions was concordant with increases in CXCR3 expression in BAL cells examined from these 
same macaques (data not shown). 
 
Expression of IFN-γ and TNF-α mRNAs is elevated in granulomatous lesions. 
Previous studies have shown that IFN-γ plays a protective role in the host response to M. 
tuberculosis, that TNF-α is important in granuloma formation and maintenance (38,79-81), and 
that both cytokines can induce the expression of subsets of chemokines (35,38). Therefore, we 
examined the patterns and levels of expression of these cytokine mRNAs in M. tuberculosis-
induced granulomatous lesions in cynomolgus macaques. TNF-α and IFN-γ mRNA+ cells were 
abundant in the granulomatous lesions of these macaques (Fig. 2I-L), but were extremely rare in 
nongranulomatous regions of lung tissue sections. These TNF-α and IFN-γ mRNA+ cells were
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 Table 3. Quantitation of chemokine, cytokine, and mycobacterial RNA expression in granulomatous lesions of cynomolgus macaques  
experimentally infected with M. tuberculosis. 
 
  Granuloma Mycobacterial IFN-γ TNF-α CXCL9/Mig  CXCL10/IP-10 CXCL11/I-TAC 
Animala  sizeb (µm2) rRNAc mRNA+ cellsd mRNA+ cellsd ISH signale ISH signale ISH signale
 
Solid 
Minimal/Moderate disease 
M15000 (12) 184,882 0.9 38.2 31.2 23.54 35.89 8.47 
M15100  (6) 157,386 0.0 6.5 2.5 9.54 6.83 1.56 
Avg (18) 175,717 0.8 27.0 21.1 18.29 17.58 6.17 
Advanced disease 
M7200 (4) 189,597 2.0 46.0 N/Af 26.96 19.37 31.07 
M11201 (12) 135,894 N/A 2.8 3.1 55.68 43.10 6.82 
M11301 (9) 131,056 1.4 39.4 11.2 49.53 42.59 27.11 
M15300 (56) 337,018 3.9 20.6 14.1 57.15 28.37 15.87 
Avg (81) 277,057 3.5 23.1 11.6 55.02 32.08 17.15 
Avg (99) 258,631 2.8 24.1 14.0 48.03 29.15 14.48 
(range)    (0 - 156) (0 - 130) (1.33 - 84.22) (0.16 - 90.53) (0.08 - 75.44) 
Caseous 
MinimalModerate disease  
M7100 (2) 1,122,068 N/A 114.0 42.0 40.23 23.48 10.01 
M15000 (1) 996,507 0.0 47.0 N/A 30.60 22.60 0.26 
M15100 (1) 1,020,000 N/A 20.0 10.0 16.86 8.17 1.99 
Avg (4) 1,065,161 0.0 60.3 26.0 29.23 18.09 5.57 
Advanced disease 
M7200 (3) 875,262 4.3 92.3 N/A 32.61 27.14 22.95 
M11201 (12) 591,442 N/A 39.6 13.0 60.11 41.27 12.88 
M11301 (6) 634,611 246.0 112.8 28.8 51.93 44.15 22.16 
M15300 (177) 678,735 4.1 49.1 28.0 51.32 32.75 11.52 
Avg (198) 675,010 45.17 51.8 26.9 51.58 33.53 12.00 
Avg (202) 682,892 45.0 51.9 26.9 51.19 33.25 11.83 
(range)    (1 - 238)  (2 - 135)  (14.14 - 99.38) (0.35 - 74.44) (0.26 - 40.16)  
aNumber of granulomas examined in parentheses. 
bAverage surface area of granulomas per 14µm section. 
cAverage number of  mycobacterial 16S rRNA focal collections per 14µm section of granuloma. 
dAverage number of mRNA+ cells per 14µm section of granuloma. 
eAverage percentage of cellular surface area comprised of autoradiographic silver grains. 
N/A, not available. f
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Figure 3. Quantitative image analysis of ISH signals for IFN-γ-inducible chemokine and 
cytokine mRNA and mycobacterial 16S rRNA in granulomatous lesions. Chemokine-, cytokine- 
and mycobacterial-specific ISHs were performed on granulomatous lung tissues from 
experimentally infected macaques. For quantitation of chemokine mRNA ISH signal, a digital 
image of each granuloma was captured. The proportion of cellular surface area covered by silver 
grains was determined using the threshold and measure tools of the MetaView software package 
(A). The numbers of IFN-γ and TNF-α mRNA+ cells per 14µm section of granuloma were 
determined for each solid and caseous granuloma (B). To measure local mycobacterial load, 
ISHs for mycobacterial 16S rRNA were performed and the numbers of mycobacterial 16S 
rRNA+ cells and focal collections were enumerated in 14µm sections of each solid and caseous 
granuloma (C). Each data point represents the value obtained for an individual granuloma. c, 
caseous; s, solid. 
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 found in the cellular regions of granulomas, and co-localized with the IFN-γ-inducible 
chemokine ISH signal (Fig. 2C-H). In contrast, no IL-4 mRNA+ cells were observed in any of  
these same tissue sections (data not shown). As a measure of local cytokine mRNA expression, 
we manually counted the cytokine mRNA+ cells in each granuloma. ISH signal for IFN-γ mRNA 
was present as a dense focal collection of silver grains (Fig. 2I,J), whereas ISH signal for TNF-α 
mRNA was present as networks of more diffuse signal (Fig. 2K,L). The numbers of IFN-γ 
mRNA+ cells per 14µm granuloma section were more abundant than TNF-α mRNA+ cells in 
both groups of animals (Fig. 3B, Table 3), with caseous granulomas harboring higher numbers of 
IFN-γ mRNA+ cells per granuloma than solid granulomas (Fig. 3B, Table 3). The average 
number of IFN-γ mRNA+ cells was 24 and 52 mRNA+ cells per 14µm section of granuloma for 
solid and caseous granulomas, respectively (Table 3), whereas the average number of TNF-α 
mRNA+ cells of was 14 and 27 mRNA+ cells per section of granuloma for solid and caseous 
granulomas, respectively. However, the mean values in Table 2 indicate that the number of IFN-
γ mRNA+ cells present in the cellular regions of granulomas were roughly proportional to 
granuloma size. 
 
Detection and quantitation of M. tuberculosis 16S rRNA in pulmonary granulomatous lesions 
 The high levels of chemokine and cytokine mRNA expression we observed in 
granulomatous lesions might be associated with high numbers of local mycobacteria or 
mycobacterial products. To address this issue, we performed ISH using a riboprobe specific for 
mycobacterial 16S rRNA. ISH with this riboprobe readily allowed detection of the mycobacterial 
16S rRNA in lung tissue sections of cynomolgus macaques (Fig. 4). No specific ISH signal was 
detected in the corresponding sense control probe experiments (Fig. 4E, inset). The ISH signal  
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Figure 4. In situ hybridization detection of mycobacterial 16S rRNA and IFN-γ mRNA in 
granulomatous experimentally infected cynomolgus macaques. ISH was performed on lung 
tissues with riboprobes specific for the mycobacterial 16S rRNA and IFN-γ RNAs and 
representative fields are presented. Mycobacterial 16S rRNA was detected in tissues with solid 
(e.g., M15000, A) and caseous (e.g., M15300, B) granulomas in animals with moderate (A) and 
advanced disease (B). A necrotic granuloma with abundant mycobacterial 16S rRNA (M11301, 
C) and IFN-γ mRNA (M11301, D) ISH signals is shown. A cavitating lesion with abundant 16S 
rRNA (M15300,E) and IFN-γ mRNA (M15300,F) ISH signals is shown. Parallel hybridizations 
with control sense riboprobes provided no autoradiographic signal (inset, E, F). Original 
magnifications, 20X (E,F), 100X (A, C, D), 200X (B). 
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 observed was typically a compact collection of silver grains or more rarely, a more diffuse 
collection of silver grains over an entire lung cell. We based our enumeration of the 
mycobacterial 16S rRNA+ focal collections on the assumption that a focus identified either a 
single bacterium or a collection of bacteria that cannot be individually distinguished.  Although 
mycobacterial 16S rRNA+ foci were detected in both solid (Fig. 4A) and caseous (Fig. 4B) 
granulomas, they were more abundant in the caseous granulomas and in the macaques with 
advanced disease compared to the macaques with minimal/moderate disease. The mycobacterial 
16S rRNA+ focal collections were observed both in the cellular regions and the central caseating 
portions of granulomas. Frequently, 16S rRNA+ focal collections were in close proximity to each 
other in cellular regions of granulomas, but the greatest ISH signals were observed in the 
acellular centers of caseous granulomas. In animal M11301 with advanced disease, 1,820 16S 
rRNA+ foci were detected in a single 14µm section of an exceptional granuloma (Fig. 4C). If we 
assume a spherical shape for this entire granuloma and the tissue section represents the largest 
diameter of the granuloma, the entire granuloma (2.5 x 1010 µm3) is estimated to harbor a 
minimum of 303,394 mycobacteria. The IFN-γ mRNA ISH signal obtained in a subjacent section 
of this same granuloma was extremely abundant (Fig. 4D), as were the intense ISH signals for 
TNF-α and CXCR3 ligand mRNAs (data not shown). 
In another animal with advanced disease (M15300), we observed a cavitating lesion (Fig. 
4E-F). This lesion, which protruded into an airway, had high numbers of mycobacterial 16S 
rRNA+ focal collections in the protruding region (Fig. 4E). The local expression of IFN-γ mRNA 
was also exceptionally abundant (Fig. 4F), with the ISH signal co-localized with the 16S rRNA+ 
foci. CXCR3 ligand mRNA expression was similarly abundant in this cavitating lesion (data not 
shown).  
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Expression of IFN-γ in the lymphocyte population 
 Interferon-γ is secreted by activated natural killer (NK) cells, cytotoxic T cells, Th1 cells 
and Th0 cells. The majority of the IFN-γ expression is attributed to the Th1 cells and we sought 
to identify which cells were expressing IFN-γ in these granulomatous tissues. We performed 
simultaneous ISH for IFN-γ mRNA and IHC for CD3, CD20 and CXCR3 protein. In these 
studies, CD3+/IFN-γ mRNA+ cells were 74% of the total IFN-γ mRNA+ cells (Fig. 5A) and IFN-
γ mRNA was rarely expressed by CD20+ B-lymphocytes (Fig. 5B). In addition, we revealed that 
a large proportion of the IFN-γ mRNA+ cells were also CXCR3+. These findings further validate 
our model that the recruitment of CXCR3+ cells into the site of the granuloma will upregulate the 
local IFN-γ production; thus, an amplification loop of IFN-γ-induced processes continue at the 
site of inflammation. We were unable to account for all of the IFN-γ mRNA+ cells. This was 
partially due to difficulty in identifying subtypes of the CD3+ lymphocytes as well as 
immunohistochemically staining NK cells and NKT cells. 
 
Characterization of the expression and distribution of T cell receptor chains in granulomas from 
cynomolgus macaques 
Lymphocytes expressing αβTCR are necessary in the formation of granulomas and 
control of infection, whereas the γδ TCR+ T cells have a protective role in the early stage of 
infection (14,31). To determine the expression of TCR receptor chain mRNAs in the 
granulomatous tissues of these cynomolgus macaques, we used ISH to specifically detect the 
presence of TCRβ and TCRγ/δ mRNA within these tissues. These studies clearly illustrated the 
presence of TCRβ and TCRγδ mRNA present in the examined granulomatous structures  (Fig.  
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Figure 5. Simultaneous ISH for IFN-γ and IHC for CD3, CD20 and CXCR3 in granulomas from 
cynomolgus macaques infected with M. tuberculosis. The majority of the IFN-γ mRNA+ cells 
were immunohistochemically stained as CD3+ lymphocytes (A), while none of the IFN-γ 
mRNA+ cells stained CD20+ (B lymphocytes, B). Additionally, the IFN-γ mRNA+ cells 
frequently were stained as CXCR3+ cells (C). Original magnifications, x400. 
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 6). We consistently found the TCRβ mRNA was dispersed and widespread throughout the 
granuloma (Fig. 6A-B), and the TCRγδ mRNA was in punctate accumulations of silver grains 
(Fig. 6C-D). The abundant expression of TCRβ mRNA compared with the expression of TCRγδ 
mRNA correlates with the current understanding that αβTCR+ T cells are the predominant cells 
and also that γδTCR+ T cells are likely complementing the type I immune response within these 
granulomas. Although our data are slightly skewed due to the fact that we only used TCRβ 
riboprobes, without inclusion of TCRα riboprobes, we are still able to see the general pattern of 
expression and distribution of the αβTCR+ and γδTCR+ T cells by this method.  
 
ISH analyses in hilar lymph node 5 weeks post-infection 
 Dendritic cells are present in the bronchoalveolar space, airway epithelium and lung 
parenchyma, and immature DC function as sentinels for inhaled pathogens (82,83). DC likely 
play a key role in the initial immune response to M. tuberculosis infection, by ingesting the 
pathogen at the site of infection and migrating to the regional lymph node. Mycobacterium-
infected DC have an upregulated expression of MHC and costimulatory molecules, which help 
DC acquire the ability to efficiently prime naïve T lymphocytes (84-86). To analyze the IFN-γ-
inducible molecules in the development of an immune response in the regional lymph node, we 
examined the hilar lymph nodes of cynomolgus macaques that were infected intrabronchially 
with M. tuberculosis Erdman strain and sacrificed at 3, 4, 5 or 6 weeks post-infection (p.i.).  
 Our studies revealed that very few granulomas were present in the lymph nodes of these 
early time-point macaques tested. We also examined lung tissues from these macaques and were 
only able to find one caseous granuloma in a 5wk p.i. macaque and no apparent signs of 
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Figure 6. ISH for TCR chains (β,γ, and δ) in granulomas from cynomolgus macaques infected 
with M. tuberculosis. The expression of TCR β chain (A, B) was abundantly expressed in a 
dense manner throughout the cellular region of the granuloma. The simultaneous expression of 
TCR γ and δ chains (C, D) was also abundant and the ISH signal was more punctate throughout 
the granuloma. Parallel ISH using sense riboprobes were performed (inset, A). Original 
magnifications, x40 (A, C), x100 (B, D). 
 
 
pregranulomatous lesions were observed in the tissues examined. Upon analysis of the ISH 
studies in the hilar lymph nodes (Fig. 7), we discovered an abundance of the IFN-γ-inducible 
chemokines as early as 3wk p.i. and the signal intensity increased with duration of infection 
(Table 4). In addition, IFN-γ and TNF-α mRNA+ cells were observed in the hilar lymph nodes as 
early as 3wk p.i., whereas IL-12p40 mRNA+ cells were not detected in these tissues (data not 
shown). We also detected low numbers of mycobacterial 16S rRNA focal collections in hilar 
lymph nodes, with the exception of M24102 (5 wk p.i.), which had a caseous  
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Figure 7. ISH analysis of a granuloma obtained from the left hilar lymph node of M24102 (5 wk 
pi).  RNAs encoding for IFN-γ (A), mycobacterial 16S rRNA (B), CXCL9/Mig (C), 
CXCL10/IP-10 (D) CCL5/RANTES (E), and CCL2/MCP-1 (F) were detected within this 
granuloma. Original magnifications, x100. 
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 Table 4. ISH for chemokine and cytokine mRNA+ cells in hilar lymph node tissue sections from 
early timepoint infections. 
 
  Number of mRNA+ cells per 14µm section             
 CXCL9 CXCL10 CCL5 CCL2    Myco. 
Animal Migb IP-10 RANTES MCP-1 IFN-γ TNF-α IL-12p40  rRNAa 
  
3wk pi. 
M12202 NTc NT NT NT 1 0 0 NT 
M24002 +/++ + - - 13 3 0 0 
 
4wk pi.
M12302 ++ ++ + ++ 51 23 0 0 
M24702 NT NT NT NT 0 NT NT 0 
 
5wk pi. 
M21902 +++ +++ - ++ 1 0 0 3 
M24102 +++ +++ + ++ 64 1 0 132d
 
6wk pi. 
M24302 ++ + + + 2 2 0 0 
M22102 + ++ - ++ 0 0 0 0  
 
aMycobacterial 16S rRNA. 
bChemokine ISH signal intensity was evaluated as follows: -, absence of ISH signal; +, 0-4 
mRNA+ cells per field (20x); ++, 5-20 mRNA+ cells per field (20x); +++, >20 mRNA+ cells per 
field (20x)
cNT, tissue repeatedly came off slide during processing. 
dMycobacterial 16S rRNA was only observed in the acellular region of the caseous granuloma. 
 
 
granuloma with 132 mycobacterial 16S rRNA focal collections within the central portion of the 
caseous granuloma found in a 14µm section. The caseous granuloma in M24102 had abundant 
expression of CXCL9/Mig, CXCL10/IP-10, and IFN-γ mRNA, revealing that regardless of 
disease state the IFN-γ and IFN-γ-inducible chemokine expression patterns are the same in 
caseous granulomas. Interestingly, we also observed CCL5/RANTES mRNA in the cellular 
portion of the caseous granuloma, as well as CCL2/MCP-1 mRNA. 
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 Expression of CCR5 ligands in granulomas from cynomolgus macaques 
 CCR5 chemokine ligands recruit T lymphocytes and macrophages, and previous studies 
have observed elevated expression levels of these chemokines in active pulmonary tuberculosis 
in humans (87-89) and in experimental infections with mice (87,90). In vitro studies have also 
shown that M. tuberculosis infection of THP-1 cells, a human macrophage cell line, induces a 
large number of genes that encode proteins involved in cell migration and homing, including the 
CCR5 ligands: CCL3/macrophage inflammatory protein (MIP)-1α, and CCL4/MIP-1β and 
CCL5/regulated on activation, normal, T-cell expressed and secreted (RANTES) (91). 
CCL3/MIP-1α, CCL4/MIP-1β and CCL5/RANTES are expressed to high levels in response to 
M. tuberculosis infection and MIP-1β and RANTES have also been shown to suppress 
intracellular mycobacterial growth, suggesting an innate immune function (92).  In addition, 
CXCR3 and CCR5 are preferentially expressed on Th1 lymphocytes (93). Immature DC also 
have been shown to migrate toward the CCR5 ligands prior to activation/maturation (94). Since 
the expression of these CCR5 ligands may be involved in the migration of multiple relevant cell 
types and may be associated with the ability to control infection, we examined the 
granulomatous tissues in these cynomolgus macaques for CCL3/MIP-1α, CCL4/MIP-1β  and 
CCL5/RANTES mRNAs by ISH. The CCR5 ligand mRNA ISH signal intensity was abundant 
within the granuloma (Fig. 8), although not as abundant as the CXCR3 ligands (Fig. 2). Even 
though the general expression patterns were very similar in distribution, CCL4/MIP-1β mRNA 
expression was the most abundant CCR5 ligand in these granulomas and CCL5/RANTES the 
least abundant. The expression of the CCR5 ligands could contribute to further skewing of the 
immune response to a type 1 immune response. The recruitment of activated Th1 cells induces a 
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 microenvironment of high IFN-γ expression, thus facilitating a further skewed microenvironment 
comprised of greater numbers of CXCR3+/CCR5+ cells at the inflammatory site. 
 
 
Figure 8. ISH analysis of the CCR5 ligands in granulomatous tissues from cynomolgus 
macaques infected with M. tuberculosis. Expression patterns of the CCR5 ligands, CCL3/MIP-
1α (A), CCL4/MIP-1β (B), and CCL5/RANTES (C), were examined by ISH. Parallel ISH using 
sense riboprobes were performed (inset; A, B and C). Original magnifications, x100. 
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 F. DISCUSSION 
 
In this study we have examined local chemokine and cytokine mRNA expression, and local 
mycobacterial burden in pulmonary granulomatous lesions resulting from intrabronchial 
infection of cynomolgus macaques with a low dose of virulent M. tuberculosis. This is one of the 
first studies of chemokine expression directly in granulomatous tissue sections. We found 
abundant expression of mRNAs encoding the proinflammatory cytokines, IFN-γ and TNF-α, as 
well as IFN-γ-inducible, CXCR3 ligands within all granulomas regardless of size or structure. 
The general absence of cells expressing these mRNAs in nongranulomatous regions of lung 
tissues suggests they play a local role in granuloma formation and maintenance.  Based on these 
findings we propose here a model for M. tuberculosis-initiated, IFN-γ-driven chronic 
inflammation in pulmonary granulomas that is similar to our model for the events occurring in 
lymphoid tissues of SIV infected rhesus macaques (68). 
Cynomolgus macaques are susceptible to M. tuberculosis, and develop disease that is 
clinically, immunologically, and pathologically similar to humans (59,69,70). Interestingly, 
approximately 40% of cynomolgus macaques infected with a low dose of M. tuberculosis were 
able to contain the infection in a subclinical state during the period of study. This clinical state 
resembles clinical latency in humans (59,70) and indicates that cynomolgus macaques are an 
appropriate animal model for latency (59,70) and reactivation (70) during M. tuberculosis 
infection. Although the proportion developing active disease in cynomolgus macaques is higher, 
it is similar to the outcome of infection in humans in which only 10% of individuals infected 
with M. tuberculosis develop overt disease.  At the tissue level, M. tuberculosis induced 
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 granulomas in cynomolgus macaques are structurally similar to granulomas that develop in 
humans.  
We have demonstrated here by direct analysis in tissue sections using ISH that there is a 
high level expression of IFN-γ-inducible chemokine mRNAs and increased numbers of IFN-γ 
and TNF-α mRNA+ cells in pulmonary granulomas.  CXCR3+ cells, which are predominantly 
activated T- and B-lymphocytes and NK cells (39,95-97), are likely recruited into the local 
environment.  Our detection of abundant CXCR3+ cells in pulmonary granulomas provides 
evidence for this recruitment.  Although not examined here, local proliferation and apoptosis are 
also likely contributing to accumulation and loss of cells, respectively, and affect overall 
granuloma size and structure.   
Previous studies of chemokine expression during M. tuberculosis infection include in 
vivo murine studies and ex vivo and limited tissue-based human studies.  Mice infected by the 
aerosol route have increases in CCL3/MIP-1α, CXCL2/MIP-2, CXCL10/IP-10 and CCL2/MCP-
1 expression in lungs (98).  In addition, granulomas elicited in mice by PPD-coated beads have a 
polarized type 1 immune response with increased expression levels of CXCL2/MIP-2, 
CXCL5/LIX, CXCL10/IP-10 and CXCL9/Mig (16,99).  In these studies, neutralization of IFN-γ 
with antibodies greatly reduced the expression of CXCL9/Mig and CXCL10/IP-10.  Human 
studies of patient-derived BAL or alveolar and peripheral macrophages revealed increased 
expression of CXCL8/IL-8, CCL5/RANTES, CCL3/MIP-1α, CCL2/MCP-1 and CXCL10/IP-10 
(9,34).  The one other ISH and IHC report of chemokine expression in human tuberculous 
granulomas demonstrated localized expression of CXCL10/IP-10, CXCL8/IL-8, and 
CCL2/MCP-1 within granulomas (34).   
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 The strategy we have used for the detection of cells producing proinflammatory 
chemokines and cytokines is targeted toward mRNA expressed by the producing cell.  This 
approach reveals the locations and numbers of cells that produce these immunomodulatory 
proteins, but does not indicate the locations or amounts of actual protein.  Although this is a 
limitation of our study, the detection of chemokine and cytokine protein is complicated by the 
diffusion of protein that will occur after release into the extracellular milieu.  The detection of 
different proteins through IHC is also complicated by the unique physiochemical properties of 
each antigen/antibody pair, in comparison to RNA/RNA hybrids, which will generally have the 
same physiochemical properties.  Our ISH strategy has the additional advantage that it can reveal 
focal changes in mRNA expression that might not be detected using population analyses of 
extracted tissue RNAs due to dilution.   
Previous in situ studies of human tuberculous granulomas identified local production of 
TNF-α and IFN-γ mRNA in all granulomatous lesions, but only a fraction of these lesions 
expressed IL-4 mRNA (100).  Our data are consistent with these findings, in that IFN-γ mRNA 
was much more abundant than IL-4 mRNA, but they differ in that we did not detect any IL-4 
mRNA with our ISH assay, as was also observed by others in human granulomas (101).  Limited 
expression of both IFN-γ and IL-4 mRNA has been suggested to be associated with progression 
of granulomas to a necrotic state (102).  However, we observed an association between the 
numbers of local IFN-γ and TNF-α mRNA+ cells and the size (and necrotic state) of pulmonary 
granulomas.  The reasons for the differences between our findings and those of others (103) are 
not clear but could include differences with respect to:  (1) the host species of study; (2) the 
disease and treatment status of the study subjects; (3) the tissue processing protocols; and/or (4) 
the ISH probe and detection strategies.  
 
 
48
 Based on our findings of abundant expression of CXCR3 ligands, IFN-γ and TNF-α in 
pulmonary granulomatous lesions, we propose a model of their contributions to the chronic 
inflammation that results in granuloma formation and maintenance, which is similar to a model 
we previously proposed for chronic inflammation in SIV infected lymphoid tissues (68).  First, 
infection of alveolar macrophages or DC leads to the induction of proinflammatory cytokines 
and chemokines, for example, by interaction of mycobacterial antigen with toll-like receptors 
(TLRs).  Additional cells are therefore recruited into the local environment.  Immune responses 
specific to M. tuberculosis develop following the trafficking of pulmonary DC to draining lymph 
nodes, which results in the trafficking of type 1 CD4+ and CD8+ T-lymphocytes to the site of M. 
tuberculosis infection, and these cells produce IFN-γ. IFN-γ function is enhanced in the presence 
of TNF-α, which is well-documented as an important cytokine in the immune response to M. 
tuberculosis and in granuloma formation (38,79-81).  Local production of IFN-γ and TLR 
stimulation will both induce the expression of CXCR3 ligands, and thus recruit CXCR3+ T-
lymphocytes and NK cells to the site of M. tuberculosis infection.  CXCR3 ligands contribute to 
further polarization of the local environment because they augment the ability of IFN-γ to induce 
additional CXCR3 ligand production and lead to a type 1 outcome following stimulation of T-
lymphocytes with polyclonal activators or specific antigens (104).  In this model, the collective 
outcome will be the establishment and maintenance of a positive feedback loop in which local 
IFN-γ production leads to the ongoing recruitment of additional IFN-γ producing cells.  Also, 
this suggests a role for IFN-γ in granuloma formation and maintenance beyond the induction of 
an antimicrobial state in infected cells.  Thus, there are common themes in M. tuberculosis and 
SIV infection of macaques that if recapitulated in humans infected with both organisms, might 
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 contribute to significantly poorer prognosis relative to individuals infected with either pathogen 
alone.   
In addition to effects of antigen-specific type 1 immune responses, M. tuberculosis bacilli 
or mycobacterial components will also have direct effects on local cytokine and chemokine 
expression profiles in and near pulmonary granulomas.  In vitro analyses have demonstrated that 
mycobacterial cell wall components induce the expression of proinflammatory cytokines via 
TLR-2 and TLR-4 (105,106). Although alveolar macrophages are initially involved in the uptake 
of M. tuberculosis, DC and monocyte-derived interstitial macrophages also phagocytose and 
process M. tuberculosis (107).  Interestingly, Lande et al. recently demonstrated that M. 
tuberculosis infection of DC leads to induction of CXCL9/Mig and CXCL10/IP-10, the latter in 
an IFN-αβ-dependent fashion (48).   
In this model we have not included other complex factors, such as complex multi-
chemokine gradients that lead to simultaneous synergistic or antagonistic signals on cells (108). 
In addition, there are likely to be negative regulatory activities occurring at the same time.  A 
candidate for such regulation is the lymphocyte cell surface protein CD26 (also known as 
dipeptidylpeptidase IV), which catalyzes the removal of N-terminal dipeptides from suitable 
substrates containing a penultimate proline or alanine (109). Cleavage by CD26 differentially 
affects the activity of specific chemokines, rendering some chemokines inactive and others more 
potent (109).  CD26 proteolytically processes all three CXCR3 ligands, and converts them to 
antagonists of CXCR3-mediated chemotaxis (110).  Determination of the roles played by such 
complex factors in granuloma formation and maintenance will require further analysis.   
To determine whether the immunologic events occurring in granulomatous lesions are due to the 
abundance of local M. tuberculosis bacilli or products, we developed an ISH strategy for the 
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 detection of mycobacterial 16S rRNA directly in tissue sections.  Among the strategies 
previously used for in situ detection of M. tuberculosis, acid-fast staining is frequently used.  
However, the sensitivity of this procedure is reduced by the common treatment of tissues with 
formalin and xylene (111).  Overall, we found a relatively low number of foci hybridizing to the 
mycobacterial 16S rRNA probe in most animals, although two animals with advanced disease 
had much higher levels of signal.  Most of the mycobacterial 16S rRNA ISH signal was localized 
to the necrotic portion of the granulomas, although some signal was localized to the cellular 
regions of caseous and solid granulomas.  Our probe for detection of M. tuberculosis will not 
discriminate between viable and nonviable organisms, or metabolically active and inactive states 
of the bacillus, but detects an RNA target that is stable and abundant (112-114).  This might 
explain the different localization of M. tuberculosis ISH signal in our study compared to those by 
Fenhalls et al. (115,116), in which ISH signal was localized to cells in the cellular and 
surrounding regions of the granulomas.  Once reaching a certain size or fluidic composition, the 
necrotic centers of caseous granulomas might provide a hospitable environment for the 
organism.  Further studies with additional probes and tuberculosis cases and stages are required 
to fully understand the importance of the numbers and states of mycobacterial organisms for 
granuloma formation and maintenance.     
In summary, through the examination of over 300 M. tuberculosis induced pulmonary 
granulomas in experimentally infected cynomolgus macaques, we have demonstrated abundant 
IFN-γ-inducible chemokine and IFN-γ and TNF-α cytokine mRNA expression within the 
granulomas.  Abundant staining of CXCR3+ cells in the same microenvironments is consistent 
with recruitment of these cells to the granulomas.  These findings, as well as our findings of 
colocalized M. tuberculosis 16S rRNA in the pulmonary granulomas, suggest that the nature of 
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 the type 1 immune response and the direct action of mycobacterial components together lead to 
the establishment of chronic inflammation.  There must be a complex balance between these 
inflammatory responses, antigen-specific responses, and negative regulatory mechanisms, that 
determines the extent to which a granuloma contains the bacillus or develops into a structure that 
allows the organism to multiply and spread within and among hosts.  Additional definition of the 
contributions of IFN-γ-inducible and other chemokines to these processes will elucidate 
mechanisms by which granulomas successfully limit or eliminate M. tuberculosis bacilli.  These 
data will be important for developing additional strategies to combat M. tuberculosis morbidity 
and mortality.   
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IV. 
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 A. PREFACE 
 
In this section I have described experiments and data related to DC associated with pulmonary 
granulomas in cynomolgus macaques infected with M. tuberculosis. I have performed ISH and 
IHC to reveal the DC populations present in the granulomatous lesions. We also performed in 
vitro studies to determine whether DC were capable of producing the IFN-γ-inducible 
chemokines in the presence of M. tuberculosis. The results indicated that multiple DC-associated 
mRNAs and antigens are present in the granulomatous lesion and DC are capable of producing 
IFN-γ-inducible chemokines upon exposure to M. tuberculosis and IFN-γ but not after a short 
exposure (4 hr) to M. tuberculosis alone. I also determined that the abundant expression of IFN-
γ-inducible chemokines is predominantly by macrophages and not DC. Therefore, I have 
determined that DC are present within the granulomatous structure, but are not responsible for 
the ample expression of IFN-γ-inducible chemokines. Interestingly, I did discover the expression 
of an IL-4-inducible molecule (DC-STAMP/FIND) at the interface between the cellular and 
acellular region of the granuloma. The function of this molecule is currently unknown. 
Altogether, these studies reveal that DC are present in granulomas observed in non-human 
primates and are not responsible for the production of chemokines examined in this study, but 
may function in the immune response in another manner, such as IL-12 secretion and T cell 
priming, most likely in draining lymph nodes. 
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 B. ABSTRACT 
 
Dendritic cells (DC) are professional antigen presenting cells that bridge innate and adaptive 
immune responses. DC are responsible for surveillance of mucosal surfaces and the presentation 
of foreign antigen by DC is a critical step in the immune response. DC have previously been 
observed in granulomas, including tuberculous granulomas. These cells were identified as 
CD11c+, fascin+ and HLA-DR+, but have not been well characterized based on other DC-
associated markers. In this study, we characterized a repertoire of DC-associated markers by in 
situ hybridization (ISH) to understand the composition of DC populations within granulomas. 
We have found abundant local expression of several DC-associated genes, including a potential 
surrogate marker for IL-4 production, DC-STAMP. To define the role of DC in local chemokine 
production, we performed simultaneous ISH/immunohistochemistry (IHC) to determine the cell 
types producing IFN-γ-inducible chemokines and performed in vitro infections of monocyte-
derived DC with M. tuberculosis in the presence of IFN-γ or M. tuberculosis infection alone. I 
observed that the majority of the IFN-γ-inducible chemokines were expressed by CD68+ 
macrophages and not by fascin+ DC, although DC were capable of producing IFN-γ-inducible 
chemokines upon IFN-γ stimulation, but not after a short M. tuberculosis infection alone. These 
findings further illustrate the presence of DC within the granulomatous structure, but provide 
evidence that the DC are not responsible for the abundant expression of IFN-γ-inducible 
chemokines.  
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 C. INTRODUCTION 
 
Tuberculosis has been classified as a global health emergency since 1993 by the World Health 
Organization (WHO) and remains a major public health problem today, causing approximately 2 
million deaths each year. Although tuberculosis is a preventable disease and curable in many 
cases, multiple demographic and socioeconomic factors render prevention and treatment 
difficult. One-third of the world’s population is infected, with 10% of the infected individuals 
developing active disease, usually within the first two years (117).  The remaining 90% of the 
infected population contain the infection and this clinical latency may persist throughout the life 
of the individual. Acquired immunity to M. tuberculosis involves multiple T lymphocyte subsets, 
including CD4+ and CD8+ T lymphocytes directed against mycobacterial antigens (29,118). 
Dendritic cells (DC) are a heterogeneous population of antigen presenting cells (APC) 
that are central to the integration of innate and adaptive immunity. DC are present in multiple 
anatomic sites, including lymphoid organs, afferent lymph, blood and nonlymphoid sites. The 
nonlymphoid sites include skin, heart, kidney, liver, kidney, gut and lung (51,119), and DC play 
a major role in the surveillance in these nonlymphoid mucosal sites, which is a large interface 
between the host and the environment. DC surveillance in these mucosal sites enhances the 
opportunity for DC to encounter microbial organisms and allows the DC play to initiate and 
modulate the host’s adaptive immune response.  
Immature DC, which survey the environment, have high phagocytic activity, but are 
inefficient at stimulating T lymphocytes (120). DC express many of the germ-line encoded 
pattern recognition receptors (PRRs) (49) that recognize pathogen-associated patterns. DC 
maturation occurs in response to pathogen-associated molecular patterns (PAMPs) signaling 
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 through the Toll-like receptors (TLRs) or in response to pro-inflammatory stimuli secreted by 
cells induced through PAMPs (121,122). Mature DC have increased expression of MHC and 
costimulatory molecules and migrate from peripheral tissues to the regional lymph nodes, where 
mature DC efficiently present the captured antigen to naïve T cells and B cells. In addition to 
presentation of antigen, DC also secrete cytokines and chemokines, while also expressing cell 
surface costimulatory molecules to coordinate the immune response by serving as a second 
signal (e.g., B7/CD28 interaction). This efficient cell-cell process may be limited in vivo due to 
the small percentage of DC in tissues and blood (51). FLT3 ligand (Flt3L)-treatment in mice can 
preferentially increase the number of functionally active DC in the lung (123), although the 
Flt3L-treated mice were more susceptible to Listeria, an intracellular pathogen (124). These 
findings support the notion that DC must be properly controlled within the physiological 
condition to optimize the host defense to an intracellular bacterial pathogen.   
 Previously, DC have been characterized by surface phenotyping or by 
immunohistochemical staining for DC-associated antigens and these data revealed that multiple 
types of DC subtypes existed. The origin of a DC can be categorized as either lymphoid or 
myeloid. Plasmacytoid DC are believed to be lymphoid-derived and express high levels of 
CD123 (125). CD123 is the IL-3 receptor α chain, which forms a heterodimer with a β chain to 
form the IL-3 receptor (IL-3R). IL-3/CD123 interactions promote proliferation and 
differentiation of multipotential stem cells and of neutrophils, basophils, eosinophils, and 
monocyte bone marrow precursors (126)  and CD123 is constitutively expressed on a variety of 
hematopoietic cells (126). In contrast, myeloid DC are characterized by the abundant surface 
expression of the adhesion molecule, CD11c. Although myeloid DC are not the only cell 
expressing CD11c, the surface expression of CD11c aids in distinguishing DC subtypes.  
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 The maturation of DC involves the increased or altered surface expression of chemokine 
receptors, MHC molecules, costimulatory and adhesion molecules, as well as reduced phagocytic 
capacity, and increased morphological changes, cytoskeleton reorganization, secretion of 
cytokines, chemokines and proteases (51). Immature DC express multiple chemokine receptors 
including CCR1, CCR2, CCR5, CCR6 and CXCR1 (57). These DC are chemotactically recruited 
primarily through CCR6 by CCL20/macrophage inflammatory protein (MIP)-3α, but also 
respond to CCL5/RANTES and CCL3/MIP-1α (57). Upon maturation of DC, CCR6 expression 
is downregulated and the increased expression of CCR7 on mature DC allows these cells to 
migrate toward the regional lymph nodes via CCL21/6-Ckine and CCL19/MIP-3β (94).  
The surface marker DC-SIGN (DC-specific ICAM-3 grabbing nonintegrin) has been used 
to classify DC as immature, and functions as an adhesion molecule. DC-SIGN has recently been 
shown to bind multiple pathogens, including M. tuberculosis (53,127-129), thereby serving as a 
broad-spectrum pathogen recognition receptor (PRR), as well as a potential receptor for 
pathogen infection of the DC. The binding of M. tuberculosis to DC-SIGN may enhance the 
dissemination of the bacilli to the regional lymph nodes by binding the bacillus and carrying the 
organism to the lymph node without degrading the pathogen, thus providing access to a 
compartment outside of the pulmonary cavity.  
Another characteristic of DC maturation state is the expression of DC-LAMP/CD208, a 
lysosome-associated membrane glycoprotein homologous to CD68 (130). DC-LAMP was 
previously reported to be induced during maturation and was exclusively found in DC and 
interdigitating DC within the lymphoid organs (130). DC-LAMP was determined to be 
associated with the MHC class II compartment prior to the translocation of MHC class II 
molecule to the cell surface and then concentrated in the perinuclear lysosomes, possibly 
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 changing the lysosome function after the transfer of the peptide-MHC class II molecule exits 
(130).  
 Another group of surface markers associated with DC maturation/activation is the B7 
family. The B7 family members are costimulatory molecules, which deliver critical signals in the 
T-cell-dependent immune responses initiated by DC. There are five members in the B7 family: 
B7.1, B7.2, B7-H1, B7h and B7-DC. Two members of the B7 family, B7.1 (CD80) and 
B7.2(CD86), provide positive costimulatory signals by binding to CD28 or counterregulatory 
signals by binding CTL-associated antigen (CTLA)-4 on T cells. In contrast, B7-H1, B7h and 
B7-DC bind PD-1, which is upregulated upon T cell activation (131,132). B7-DC was shown to 
strongly costimulate IFN-γ production, while not stimulating IL-4 and IL-10 production, 
suggesting that B7-DC may be an important mediator of Th1 responses (132). The expression of 
B7-DC was restricted to DC, while the other B7 family members are broadly distributed on 
multiple hematopoietic and nonhematopoietic tissues (132). 
 Interestingly, CD11c+ DC have been observed within the granulomatous structures in 
patients with tuberculosis with a simultaneous reduction in CD11c+ DC in the blood (56). Uehira 
et al., demonstrated that the DC population infiltrating the lymphocyte area of the tuberculous 
granuloma was fascin+, CD11c+ and HLA-DR+. In another study, DC pretreated with bacillus 
Calmette-Guerin (BCG) augmented the polarization of Th1 cells (133), suggesting that 
trafficking of DC to the site of the granuloma further skewed the immune response toward     
type 1.  
 In the studies described in this section, I sought to characterize further the DC population 
within the granulomatous lesion using DC-associated markers not previously examined in tissues 
and not applied to an experimental nonhuman primate model of tuberculosis. I also sought to 
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 determine whether DC express CXCR3 ligands upon infection with M. tuberculosis, treatment 
with IFN-γ, or  treatment with a proinflammatory inhibitor to IFN-γ responsiveness, IL6.  Lastly, 
I sought to determine whether DC in situ were responsible for the abundant expression of 
CXCR3 ligands observed in the granulomatous lesions (Fig. 2). These studies have revealed an 
abundance of DC-associated molecules at the site of the granulomatous lesion, including fascin 
(p55) mRNA and protein, and CD11c mRNA. I determined that DC were capable of producing 
CXCR3 ligands upon IFN-γ treatment by 4 hr, but not due to M. tuberculosis infection after 4 hr. 
However, after an 8 hr infection, monocyte-derived DC did produce CXCR3 ligands from M. 
tuberculosis infection alone. Finally, we also revealed that IFN-γ-inducible chemokine mRNAs 
were predominantly expressed by CD68+ macrophages rather than fascin+ DC within the 
granulomatous lesion. Although DC may perform an important immune function at the site of 
the granuloma, macrophages were responsible for the abundant expression of IFN-γ-inducible 
chemokines associated with granulomatous lesions. 
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 D. MATERIALS AND METHODS 
 
Animals and tissue processing 
All animal studies were performed under the guidance and approval of the University of 
Pittsburgh Institutional Animal Care and Use Committee. Adult cynomolgus macaques were 
inoculated with a low dose (approximately 25 colony forming units) of virulent M. tuberculosis 
(Erdman strain) via bronchoscope into the lower right lobe, as described elsewhere (70). 
Infection was allowed to proceed until macaques reached disease states that spanned a spectrum 
from no apparent disease to advanced disease. At necropsy, tissues were collected and fixed in 
4% paraformaldehyde/1X phosphate buffered saline (PF/PBS) for 5 hr at 40oC, as previously 
described (71). After fixation, the tissues were cryoprotected and snap frozen in isopentane 
cooled on dry ice to -65oC. 
 
Immunohistochemistry 
Immunohistochemical staining of 14µm tissue sections was performed using cell-type specific 
antibodies for fascin (clone 55K-2, Dako, Carpinteria, CA) and CD68 (clone KP1, Dako). Tissue 
sections were pretreated in 0.01M sodium citrate (pH 6.0) by microwaving followed by 
application of the primary antibody (diluted in 1X PBS) to the tissues for 1 hr in a humid 
chamber at room temperature. Primary antibodies were detected with the PicTureTM-Plus 
detection system (Zymed Laboratories), using 3,3’-diaminobenzidine (DAB) as the final 
substrate.  
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 In situ hybridization (ISH) 
Riboprobe syntheses and ISHs were performed on 14µm tissue sections as described (68,71,72). 
Cytokine and chemokine mRNAs were detected by ISH using gene-specific riboprobes of DC-
associated genes. Plasmids (pGEM-T, Promega, Madison, WI) containing macaque DC-LAMP, 
DC-SIGN, B7-DC, DC-STAMP, CCR6, CCR7, CD123 and CD11c were generated and 
sequenced in our laboratory (134). Autoradiographic exposure times were 8 days for DC-LAMP, 
DC-SIGN, B7-DC, DC-STAMP ISHs and 21 days for CCR6, CCR7, CD123 and CD11c ISHs.  
 
In situ hybridization and immunohistochemistry 
In situ hybridizations (ISHs) and simultaneous ISH and immunohistochemistry (IHC) were 
performed as described (68,71). 
 
Isolation of monocyte-derived DC 
Peripheral blood mononuclear cells were isolated from human buffy coats (Central Blood Bank) 
by Ficoll density gradient centrifugation (Histopaque, Sigma-Aldrich, ST. Louis, MO) or from 
cynomolgus macaque peripheral blood by Percoll gradient (Amersham Biosciences). CD14+ 
monocytes were isolated by positive selection using anti-CD14 microbeads, per the 
manufacturer’s recommendations (Miltenyi Biotech, Auburn, CA).  The purity of CD14+ cells 
after enrichment was >93% as determined by flow cytometry. CD14+ cells were cultured in 
RPMI 1640 media supplemented with L-glutamine, nonessential amino acids, 1M HEPES, 10% 
heat-inactivated fetal calf serum and penicillin/streptomycin for 5 days; the medium was changed 
on days 2 and 4.  
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 DC infection with M. tuberculosis 
Immature human DC (day 5 culture of monocyte-derived DC) were harvested using 20mM 
EDTA to remove adherent cells and centrifuged at 1200 rpm for 10 min. The DC were counted 
and resuspended to a concentration of 1 x 106 cells/ml in DC media without antibiotics. The cells 
were infected with M. tuberculosis Erdman strain at an MOI of 4 with or without 100 ng/ml of 
IFN-γ and 100ng/ml of IL-6. The cultures were incubated in 5% CO2 at 37oC for 4 or 8 hours. 
The infected cultures were then centrifuged at 1200 rpm for 7 min at room temperature and the 
supernatant was removed. The cells were resuspended in 1ml Trizol (Invitrogen Corporation, 
Carlsbad, CA) and total RNA was isolated by Trizol and chloroform extraction.  
 
Real-time RT-PCR of CXCL9/Mig and CXCL11/IP-10 
For each specimen, 400ng of total RNA was reverse transcribed using random hexamers and 
Superscript II reverse transcriptase (Life Technologies, Carlsbad, CA) in a 100µl reaction. 
Reverse transcriptase (RT)-negative controls were also performed in parallel with 400ng of each 
RNA sample. For PCR amplification, 5µl of each cDNA and 50nM of forward and reverse 
primers for either CXCL9/Mig or CXCL10/IP-10 mRNA were used. β-glucouronidase (β-GUS) 
was used as the endogenous control to normalize for the input of RNA.  The primers were 
designed using Primer Express software (PE Applied Biosystems) and contained the following 
sequences: SSRhMigF2 (5’-CAGATTCAGCAGATGTGAAGGAA-3’), SSRhMigR2 (5’-
ACGTTGAGATTTTCTAACTTTCAGAACTT-3’), SSRhIP10F4 (5’-
TTGCTGCCTTGTCTTTCTGACTCTAA-3’), SSRhIP10R4 (5’-
AATTCTTGATGGCCTTCGATT-3’), SSbGUSF3 (5'-CTCATCTGGAATTTTGCCGATT-3') 
and SSbGUSR3 (5'-CCGAGTGAAGACCCCCTTTTTA-3').  The PCR reactions were cycled at 
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 95oC for 12 min followed by 40 cycles of 95oC for 15 s and 60oC for 1 min on an ABI Prism 
7000 Sequence Detection System (PE Applied Biosystems, Foster City, CA) using SYBR Green 
PCR master mix (PE Applied Biosystems, Foster City, CA). The relative expression levels of 
CXCL9/Mig and CXCL10/IP-10 mRNA were calculated using the comparative CT method 
(135)(Anonymous, ABI Prism 7700 Sequence detection system: relative quantitation of gene 
expression ([user bulletin #2], 1-36.1997, Norwalk, CT, Perkin-Elmer Corp.), with mock 
infected DC cultures used as a calibrator.  
 
DC-STAMP expression in cytokine-treated cells by real-time RT-PCR 
Rhesus macaque monocyte-derived DC were differentiated in GM-CSF plus either IL-4 or IL-15 
(cellular RNAs were provided by Dr. Russ Salter, University of Pittsburgh). Human CD19+ B 
cells were treated with CD40L and IL-4 (cell cultures were provided by Dr. Charles Rinaldo, 
University of Pittsburgh). The total RNA was extracted from treated cells by Trizol extraction 
and SYBR Green real-time RT-PCR was performed as described above using DC-STAMP-
specific primers - CLF.DC-STAMP.F2 (5’-TAGATTATCTGCTGTATCGGCTCATTT-3’) and 
CLF.DC-STAMP.R5 (5’-AAGAATCATGGATAATATCTTGAGTTCCTT-3’). β-GUS was 
utilized as an endogenous control as described above. 
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 E. RESULTS 
 
To characterize the DC populations within the tuberculous granulomas, we examined pulmonary 
granulomas from cynomolgus macaques, which were inoculated intrabronchially with a low dose 
of virulent M. tuberculosis (Erdman strain).  All animals examined in this study were 
successfully infected and detailed clinicopathological and bacteriological findings have been 
presented elsewhere (70). These animals varied in their rates and extents of disease progression, 
but all had macroscopic (gross) lesions within lung tissues at necropsy. The pulmonary 
granulomas had abundant expression of IFN-γ-inducible chemokines and proinflammatory 
cytokines (60) and in this study we sought to define the DC population(s) present in granulomas 
in a relevant nonhuman primate model of tuberculosis. The determination of the type and 
maturation of DC in these granulomas may further clarify the potential role of DC within the 
granulomatous structure. 
 
Expression of DC-associated genes in granulomatous lesions 
To define the DC populations present in the pulmonary granulomatous lesions, we performed 
immunohistochemistry and in situ hybridization for multiple DC targets. Given that there are two 
major types of DC, myeloid and plasmacytoid, we performed ISH for their respective CD11c and 
CD123 markers to determine whether the DC populations in the lungs were more generally of 
the myeloid or plasmacytoid lineage. Within granulomatous lesions, we found that CD11c 
mRNA (Fig. 9A-B) was abundant and was dispersed throughout the granuloma. Previous studies 
have used CD11c in combination with other markers to label DC; however, some populations of 
macrophages can also express CD11c. In addition, we examined the expression of CD123  
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Figure 9. In situ hybridization for DC-associated mRNAs in pulmonary granulomatous tissues 
from cynomolgus macaques infected with virulent M. tuberculosis. The expression of CD11c (A, 
B) and CD123 (C, D) mRNAs were examined to determine the presence of myeloid and 
plasmacytoid DC. Fascin-positive cells were also identified in the granulomatous tissues by IHC 
(E, F) and ISH (G, H), with the isotype control shown (inset, E). The expression of fascin was 
restricted to DC as shown by double IHC (I, J), with fascin-positive cells (DC, brown) and 
CD68-positive cells (macrophages, red). Original magnifications, x40 (D, G), x100 (A, C, I), 
x400 (B, D, F, H), x600 (J). 
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 mRNA (IL-3 receptor α chain), which is expressed abundantly by plasmacytoid DC. We found 
that CD123 mRNA (Fig 9C-D) was also expressed in the granulomatous lesion and that the 
expression was dispersed throughout the granuloma, but at a much lower intensity than CD11c 
(Fig. 9A-B).  
Fascin (p55) is a 55kDa protein involved in the formation of microfilament bundles and 
is expressed by interdigitating and follicular DC within the lymph node (136), and by DC in 
thymus, spleen and peripheral blood (137,138). Fascin mRNA (Fig. 9G-H) and fascin protein 
(Fig. 9E-F) had relatively the same distribution patterns in these granulomatous lesions, with 
staining observed throughout the entire lung tissue. The fascin+ cells were distinct from 
pulmonary macrophages as shown by simultaneous immunohistochemical staining for fascin and 
CD68 (Fig. 9I-J). Taken together, the mRNA expression of fascin antigen and mRNA suggests 
that myeloid DC are present in the granulomatous lesions and that the abundant expression of 
CD11c mRNA is predominantly being expressed by macrophages. 
To determine if the DC were the major producers of IFN-γ-inducible chemokine mRNA 
in the granuloma, I performed simultaneous ISH for chemokine mRNA and IHC for cell-type 
specific markers. These experiments revealed that CXCL9/Mig and CXCL10/IP-10 mRNAs 
within granulomas were expressed mainly by macrophages (Fig 10A-B), occasionally by DC 
(Fig. 10C-D) and not by B cells (Fig. 10E-F). 
In addition to identifying DC expressing lineage-specific (CD11c, CD123) and pan-DC 
(fascin) markers, we sought to obtain data regarding the maturation/activation states of the 
dendritic cell populations.  Previous studies have shown that DC-SIGN is abundantly expressed 
by immature DC and as the DC captures antigen, matures, and becomes activated, the expression 
of DC-SIGN decreases (51). DC-LAMP is a lysosomal marker homologous to CD68 in  
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Figure 10. Simultaneous in situ hybridization for CXCL9/Mig or CXCL10/IP-10 mRNAs 
combined with immunohistochemical staining for macrophages (CD68), DC (fascin) or B 
(CD20) cells. CXCL9/Mig (A, C and E) and CXCL10 (B, D, F) mRNA was expressed by CD68+ 
macrophages (A, B), less frequently by fascin+ DC (C,D) and rarely by CD20+ B cells (E, F). 
Original magnifications, x100 (A-F), x400 (inset) . 
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 macrophages and DC-LAMP expression in DC is increased during maturation and activation 
(130). We also sought to examine the distribution of mRNA for the costimulatory molecule B7-
DC, which is highly restricted to DC and a potential mediator of Th1 response (132).  
We performed ISH for DC-SIGN, DC-LAMP and B7-DC mRNAs on these 
granulomatous tissues. Although previous studies in rodents have shown that pulmonary DC 
populations have functional characteristics of an immature DC (120), we did not detect any DC-
SIGN mRNA within these granulomatous tissues utilizing ISH. However, we were able to detect 
DC-SIGN mRNA in submucosal areas of the lung tissues (Fig. 11A) and in hilar LN and spleen 
tissues of these macaques (Fig. 11B). In situ hybridizations for mRNA encoding the lysosomal 
marker DC-LAMP revealed that (1) DC-LAMP+ cells encircled the granulomas  (Fig. 11C) and 
(2) the ISH signal patterns in the normal lung architecture were consistent with our previous 
findings in rhesus macaques (139). All granulomas had this characteristic distribution of DC-
LAMP mRNA+ cells. The cells expressing DC-LAMP mRNA were abundant on the outside 
surfaces of the granulomas with a small number of DC-LAMP mRNA+ cells also observed 
within the cellular portion of the granuloma. These findings suggested that DC were present in 
and around the granulomatous structure.  
However, two recent reports have shown that DC-LAMP protein co-localizes with 
markers for human type II pneumocytes (140,141). Thus, we examined whether the DC-LAMP 
ISH signal within the lung was consistent with these previous reports by performing ISH for 
surfactant B mRNA, which is expressed by type II pneumocytes (142). ISH on subjacent sections 
for DC-LAMP (Fig. 11D, left) and surfactant B (Fig. 11D, right) mRNAs exhibited the same 
distribution patterns. These data indicate that the DC-LAMP mRNA expression observed in 
these tissues is predominantly contributed by type II pneumocytes lining the alveolar spaces or  
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Figure 11. In situ hybridization for additional DC-associated mRNAs in pulmonary 
granulomatous tissues from cynomolgus macaques infected with virulent M. tuberculosis. The 
expression of DC-SIGN was rare in lung tissues (A) and was more abundant in the medullary 
sinuses of hilar lymph nodes (B). DC-LAMP mRNA+ cells were abundant surrounding the 
granuloma and dispersed within the cellular region of the granuloma (C). Further 
characterization of these cells showed that the DC-LAMP mRNA+ cells (D, left) were 
colocalized with type II pneumocytes expressing surfactant B mRNA (D, right). DC-STAMP 
mRNA expression (E) was confined to the interface between the caseation and cellular region of 
the granuloma, whereas B7-DC mRNA (F) was dispersed throughout the entire granuloma 
structure, but with increased intensity near the same interface. Focal collections of CCR6 mRNA 
(G) were spread out over the granuloma, whereas CCR7 mRNA (H) was more focalized to 
distinct regions of the granuloma. Original magnifications x40 (A, C, E-H), x100 (B), x400 (D). 
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 trapped within the granulomatous structure forming around them, and suggest that there are only 
few mature DC in the pulmonary granulomas. 
Another marker that is expressed by activated DC is the B7 family costimulatory 
molecule, B7-DC, which is considered to be DC-restricted. Unlike DC-LAMP, B7-DC ISH 
signal (Fig. 11F) is highly dispersed throughout and did not label distinctive cells, consistent 
with the cells potentially having numerous intertwining DC processes. 
Surveillance of the pulmonary mucosal interface with the external environment is 
performed by DC characterized by a rapid turnover (143). One of the mechanisms influencing 
the movement of DC is the interaction between chemokine and chemokine receptors. Immature 
DC express abundant CCR6, which is signaled by CCL20/MIP-3α, whereas mature DC express 
CCR7, which is signaled by CCL19/MIP-3β and CCL21/6-Ckine (144,145). Therefore, we 
sought to determine the mRNA expression patterns of these two chemokine receptors within 
pulmonary granulomatous tissues using ISH. We detected CCR6 mRNA expression in the lung 
tissues examined. The expression pattern was dispersed diffusely around the granuloma (Fig. 
11G). In contrast, CCR7 mRNA was abundant in the lung tissues, specifically in the 
granulomatous lesions (Fig. 11H). In addition, CCR6 and CCR7 mRNAs were abundantly 
expressed in the hilar lymph nodes and the expression was mutually exclusive. 
 
Expression of CCR6 and CCR7 ligands in granulomas from cynomolgus macaques 
Maturation and migration of DC from the mucosal surfaces to the regional lymph nodes 
is associated with their activation (51) and responsiveness to expressed chemokines (146). 
Immature DC are dispersed throughout peripheral tissues to function as sentinels surveying the 
sites for foreign antigens. In a study using intranasal delivery of BCG, DC were recruited to the 
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 lungs quickly to induce a type 1 immune response (133). In addition, Legge et al., have 
demonstrated that respiratory DC have an accelerated migration during the first 24 hr after 
pulmonary virus challenge, but after that time the DC are refractory to further migration (147). 
Thus, we sought to determine if chemokines, which specifically recruit immature or mature DC, 
were present in the granulomatous lesion. Immature DC are characterized as CCR6+, which is 
the receptor for CCL/20MIP-3α, and the mature DC are characterized as CCR7+, which is the 
receptor for CCL19/MIP-3β and CCL21/6Ckine. Thus, I performed ISH for CCL/20MIP-3α, 
CCL19/MIP-3β and CCL21/6Ckine mRNA in the granulomatous tissues of cynomolgus 
macaques infected with M. tuberculosis. Interestingly, we found very few MIP-3α+ cells 
expressed within the granuloma (Fig. 12A), whereas the CCR7 ligands (CCL19/MIP-3β and 
CCL21/6Ckine) were more abundant. CCL19/MIP-3β mRNA was expressed as a dispersed 
signal in the cellular portion of the granulomas and was concentrated just outside the acellular 
region of the caseation (Fig. 12B). In contrast, ISH signal for CCL21/6Ckine mRNA was intense 
in specific sites along the outer portion of the cellularity of the granuloma (Fig. 12C). Our 
laboratory is investigating this expression profile further as we think that CCL21/6Ckine is a 
suitable marker for lymphatic vessels. While we were unable to show large numbers of immature 
DC at the site of the granuloma, we also found very little CCL/20MIP-3α mRNA within the 
granuloma, suggesting that immature DC were not recruited to the existing granuloma structures. 
However, we found both CCR7 ligands within the granulomatous structure. The distribution of 
the silver grain patterns is consistent with CCR7 mRNA expression previously described (Fig. 
11H), suggesting that mature DC may be present in the granuloma and possibly are expressing 
these CCR7 ligands themselves. Previously, Krupa et al., found a similar phenomenon in giant 
cell arteritis, a granulomatous vasculitis, which contained mature DC expressing CCR7. These  
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Figure 12. ISH analysis of CCL/20MIP-3α, CCL19/MIP-3β and CCL21/6-Ckine mRNA in the 
granulomatous tissues of cynomolgus macaques infected with M. tuberculosis. CCL/20MIP-3α 
(A) mRNA was relatively rare within the cellular region of the granuloma. CCL19/MIP-3β (B) 
mRNA was more abundant and expressed as a dispersed ring on the internal portion of the 
cellularity of the granuloma. CCL21/6Ckine (C) mRNA was detected as intense focal 
collections, presumed to identify lymphatic vessels. Original magnifications, x100. 
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 granulomas also abundantly expressed CCL18/pulmonary and activation-regulated chemokine 
(PARC), CCL19/MIP-3β and CCL21/6Ckine (58). Altogether, their data suggested that DC in 
granulomas may be trapped and prevented from migrating to the region lymph nodes, thus, 
maintaining T cell activation and granuloma formation. This may also be occurring in these 
granulomas, where we detect fascin+ DC, CCR7+ cells and the CCR7 ligand-producing cells. 
 
Abundant expression of Interleukin-6 within the granulomatous lesion 
Interleukin (IL)-6 is a pleitropic cytokine that has roles in the immune response during 
inflammation, hematopoiesis and the differentiation of T cells. IL-6 has been shown to suppress 
T cell responses in mycobacterial infections, which may account for unresponsiveness apparent 
in both human and murine mycobacterial disease (148,149). IL-6 is potentially involved in the 
initial innate response to M. tuberculosis as observed by the increased early bacterial burden and 
low IFN-γ production following low dose aerosol infection in IL-6-/- mice (150). The 
development of acquired immunity correlated with mice survival and memory responses 
remained intact in the IL-6-/- mice (150). A key observation described in the previous studies 
with IL-6 and M. tuberculosis infection is the reduced production of IFN-γ and an increased 
production of IL-4 in IL-6-/- mice (148). Saunders et al., demonstrated that IL-6 is responsible for 
inducing the production of IFN-γ early in infection, but that IL-6 is not critical to the 
development of specific immunity to M. tuberculosis (150). Interestingly, another study 
examined the ability of IL-6 secreted by M. tuberculosis-infected macrophages to inhibit the 
responses of uninfected macrophages to IFN-γ, illustrating a bystander effect (151). Therefore, 
we sought to determine if IL-6 was expressed within the granulomatous lesions using ISH for IL-
6 mRNA. We found that IL-6 mRNA expression was abundantly expressed within the cellular 
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 regions of the granuloma (Fig. 13A) and in inflamed lung tissues (Fig. 13B), although IL-6 
mRNA expression was virtually absent from the nongranulomatous tissues. These studies in 
conjunction with previous studies of IL-6 effect on the immune response suggests that IL-6 may 
be inhibiting the IFN-γ responses of newly recruited, uninfected macrophages, but none of the 
current studies have examined the potential inhibitory role of IL-6 on DC responsiveness to  
IFN-γ.  
 
Figure 13. ISH for IL-6 mRNA in lung tissues of cynomolgus macaques infected with M. 
tuberculosis. IL-6 mRNA expression was observed as a focal collection of silver grains in outer 
portion of the cellular region of the caseous granuloma (A) and in the alveolar walls of the 
inflamed lung tissue (B) juxtaposed to the caseous granuloma. Original magnifications, x100. 
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 Table 5. Summary of ISH studies performed on granulomas from cynomolgus macaques. 
 Region of the Granulomaa    
 
DC-associated  marker External  Cellularb Interface 
 Surfaceb  Cellular/Acellularb 
  
 
CD11c + ++ +++ 
CD123 + + + 
DC-SIGN - - - 
DC-LAMP ++ + - 
B7-DC - + +  
DC-STAMP - - ++ 
CCR6 - + - 
CCR7 - + - 
 
aOver 250 granulomas were examined for all eight DC-associated markers in three different 
lobes from 9 cynomolgus macaques.  
bISH analysis was scored as follows: -, no ISH signal, +, rare focal collections or diffuse spray of 
silver grains observed; +, low intensity of silver grains covering cells; ++, mild intensity of 
silver grains covering cells; +++, high intensity of silver grains covering cells. 
 
DC-STAMP/FIND is expressed in pulmonary granulomas and is induced upon IL-4 stimulation 
 DC-STAMP, DC-specific transmembrane protein, is a multi-membrane spanning 
molecule that was initially described as being expressed preferentially by DC (152). My analysis 
of related sequences in the GenBank database revealed that FIND was identical in nucleotide 
sequence. FIND (IL-Four INDuced) was initially described as a transmembrane molecule 
expressed by mononuclear phagocytes deactivated by IL-4 and not IL-10 treatment (153). Next, I 
examined the expression of DC-STAMP/FIND mRNA in granulomatous tissues and found that 
cells expressing this IL-4-inducible mRNA were exquisitely localized to the cellular and 
acellular interface of caseous granulomas (Fig. 11E), whereas DC-STAMP mRNA was not 
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 observed in the solid granulomas or in normal lung tissue.  Given that DC-STAMP and FIND are 
the same molecule, and that FIND was known to be induced by IL-4 (153), I reasoned that DC-
STAMP could potentially serve as a locally expressed surrogate marker for local IL-4 
production. In a previous study, IL-4 mRNA could be detected in certain human granulomas 
(27), but we were not able to detect IL-4 mRNA within these granulomas from cynomolgus 
macaques. To determine whether DC-STAMP/FIND could serve as a surrogate marker for IL-4 
expression, I measured DC-STAMP/FIND mRNA expression in rhesus macaque monocyte-
derived DC, which were differentiated in GM-CSF plus either IL-4 or IL-15. By real-time RT-
PCR and gel electrophoresis, we detected DC-STAMP mRNA in the cell populations that were 
derived with IL-4, but not in the IL-15-derived DC (Fig. 14, Table 6).  These data confirmed that 
human monocyte-derived DC using GM-CSF and IL-4 expressed DC-STAMP, as previously 
reported (152), but that monocytes differentiated without IL-4 did not express this IL-4-inducible 
molecule. To further examine the potential of IL-4 to induce the production of DC-associated 
genes in other cells, we examined the ability of freshly-isolated CD19+ cells to express DC-
STAMP/FIND mRNA by real-time RT-PCR. We determined that the freshly-isolated human 
CD19+ B cells were unable to produce DC- STAMP/FIND, but that CD40L and IL-4 treated 
CD19+ B cells were capable of expressing DC-STAMP/FIND (Table 6). While CD40L treatment 
has been previously shown to downregulate DC-STAMP in monocyte-derived DC (152), it is 
possible that IL-4 treatment has overcome the downregulating capacity of the CD40L and IL-4 
has induced a mild upregulation of DC-STAMP in CD19+ B cells. 
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1      2       3     4     5      6      7            2      3     4      5     6      7            8      9             10   11 
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Sample 2 
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β2m DC-STAMP 
GM-CSF + IL-4 
A. 
 
 
 
 
β2m DC-STAMP 
GM-CSF + IL-15 
Sample 1 
β2m DC-STAMP 
GM-CSF + IL-15 
Sample 2 
B. 
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Figure 14. Electrophoretic gel of DC-STAMP/FIND amplification in dendritic cells derived from 
rhesus macaque monocytes with IL-4 or IL-15. The amplification of DC-STAMP/FIND is 
observed (red squares, lane 2 and 8, A) in IL-4 derived DC, while DC-STAMP/FIND was not 
amplified in DC cultures derived with IL-15 (lane 2, B). The 1 kb marker is in Lane 1, rhesus 
macaque monocyte derived DC derived with GM-CSF + IL-4 (A) in lanes 2-7 or IL-15 (B) in 
lanes 2-7, rhesus macaque precursor DC1 cells (pDC1)derived with GM-CSF + IL-4  in lanes 8 -
9, and human U937 monocyte cell line in lanes 10-11. Parallel amplification of b2m was 
performed and observed in lanes 5-7 (A and B), 9 and 11. No reverse transcriptase controls  
(NRT, lane 6, A and B) and NRT plus genomic DNA controls  (lane 7, A and B) were also 
performed. 
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 Table 6. Real-time RT-PCR analysis of DC-STAMP/FIND expression in rhesus macaque 
monocyte-derived dendritic cells and human CD19+ B cells. 
 
Sample ∆CTa 2-∆∆CT Band  
  (Electrophoresis)  
 
Dendritic cellsb 
 
GM-CSF + IL-4 15.7 1.32 + 
GM-CSF + IL-4 16.6 0.71 + 
GM-CSF + IL-15 NDc ND - 
GM-CSF + IL-15 ND ND - 
 
pDC1d 16.1 1.00 + 
 
 
CD19+ B cellse,f 
No treatment ND 1.00 - 
CD40L + IL-4 8.78 >1.12 + 
 
 
a∆CT, change in CT value was provided here if there was no mRNA detected. β2microglobulin 
was used as the endogenous control. 
bRhesus macaque monocyte-derived DC were differentiated with GM-CSF plus either IL-4 or 
IL-15. 
cND, not detected after 40 cycles. 
dpDC1 are precursor DC (lin-CD11c+) isolated from rhesus macaque peripheral blood and treated 
with GM-CSF and IL-4. 
eβGUS was used as the endogenous control. 
fTo determine the fold change in the DC-STAMP expression for CD40L + IL-4 treatment, we 
used 40.0 as the CT value for the freshly isolated human CD19+ B cells, although it was below 
our level of detection. 
 
 
Expression of CXCL9/Mig and CXCL10/IP-10 in human monocyte-derived dendritic cells 
To determine whether DC could be induced to produce the CXCR3 ligands in response to 
M. tuberculosis infection and/or IFN-γ induction, we derived DC from CD14+ monocytes 
isolated from human peripheral blood. Human peripheral blood was used instead of cynomolgus 
macaque peripheral blood, because the number of CD14+ monocytes isolated from macaque 
peripheral blood was low and the volume of blood we were able to use was limited. The isolated 
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 CD14+ cells were incubated for 5 days in medium supplemented with GM-CSF and IL-4 to 
induce differentiation into immature DC. On day 5, the monocyte-derived DC were examined for 
surface phenotype to reveal >95% of the population expressed DC-SIGN, as determined by flow 
cytometry. The monocyte-derived DC were infected with M. tuberculosis (Erdman strain) at a 
multiplicity of infection (MOI) of 4 for 4h and then RNA was harvested from the infected cells. 
The expression of CXCL9/Mig and CXCL10/IP-10 mRNA was quantitated by SYBR Green 
real-time RT-PCR. CXCL9/Mig mRNA was not detectable in the mock and M. tuberculosis-
infected cultures after 4 hr (Table 4.3), whereas CXCL10/IP-10 mRNA was only upregulated 
(>5-fold) in two samples of 4 (Table 4.3). Similar to previous studies showing that IFN-γ induces 
CXCR3 ligand expression (96,154,155), I observed an induction of the CXCR3 ligands (1,900- 
to 56,000-fold increase) by monocyte-derived DC upon IFN-γ treatment in a dose-dependent 
manner after a 4 hr M. tuberculosis infection. In a preliminary study, we observed appreciable 
expression of IL-6 mRNA in granulomatous tissues (Fig. 13) and the inhibitory effects of IL-6 
on IFN-γ signaling in DC has not been well studied. Therefore, we also treated the monocyte-
derived DC with IL-6 to determine if IL-6 treatment would reduce the DC responsiveness to 
IFN-γ. Interestingly, IL-6 had a mildly suppressive activity on CXCL9/Mig (1.5-fold) and 
CXCL10/IP-10 (1.2-fold) expression with IL-6 treatment. Taken altogether, these findings reveal 
that IFN-γ-induced expression of CXCL9/Mig and CXCL10/IP-10 does appear to be influenced 
by IL-6 treatment of the monocyte-derived DC. 
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Table 7. Real-time RT-PCR analysis of CXCL9/Mig and CXCL10/IP-10 expression in M. tuberculosis-infected dendritic cells. 
 
 CXCL9/Mig CXCL10/IP-10 
 IFN-γ     Mtb-infected        Mtb-infected  
 (µg/ml) mock Mtb-infected IFN-γ IFN-γ+IL-6 mock Mtb-infected IFN-γ IFN-γ+IL-6
   
Sample # 
   
human   
KS84044 10 NDa,b,c ND > 1,951 4,705 1.0 ND > 787 > 1,314 
 (1.0) (> 4.5) (> 5,113) (> 3,956) (1.0) (> 47) (> 4,040) (> 826) 
 
KJ67282 10 ND ND  > 5,874 > 5,442 1.0 > 5 > 8,364 > 3,019 
 
 
KM13687 100 1.0 ND > 56,267 32,768 1.0 > 5 > 37,381 > 28,133 
  (1.0) (> 82)  (> 48,645)  (> 46,988) (1.0) (> 60)  (> 3,769)  (> 3,795) 
 
KM84905 100 ND ND  > 11,268 8,481 ND >1.0 >24,147 >20,757 
  (ND) (> 147)  (> 20,032) (> 12,590) (ND) (> 2,778) (> 6,165) (> 431) 
 
macaque 
M23102f 100 ND ND  > 4,040 NTd ND ND 292 NT 
M23202f 100 1.0 2 NT NT ND 3 NT NT  
 
 
aFold expression of CXCL9 and CXL10 in monocyte-derived DC after 4hour incubation (8 hr incubation in parentheses) in the presence or 
absence of M. tuberculosis Erdman strain and cytokines.  
bIn order to calculate fold expression changes, a default CT value of 40.0 was used if there was no mRNA detected. βGUS was used as the 
endogenous control. 
cND, not detected. 
dNT, not tested due to low number of cells in culture. 
fOnly 106 cells from cynomolgus macaques were infected at MOI of 4 due to low cell yields. 
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 F. DISCUSSION 
 
In this study we have examined local DC-associated mRNA expression in pulmonary 
granulomatous lesions resulting from intrabronchial infection of cynomolgus macaques with a 
low dose of virulent M. tuberculosis. Previously, DC within the granulomatous lesion have only 
been characterized by protein expression of CD11c, fascin and HLA-DR (56). Thus, we have 
analyzed the mRNA expression profiles of several DC-associated genes by ISH. These studies 
are the initial analyses of the DC population within a granulomatous lesion using this extensive 
array of DC-associated markers. Whereas some of these markers may be expressed by cells other 
than DC, the results here clearly show a wealth of information to further tease out the cell 
populations present within the granuloma and helps further distinguish between the cells 
expressing immune molecules. The function of DC within a granulomatous lesion is still unclear, 
but the presence of IL-12-producing DC within the granuloma (54) and the reported presence of 
newly arriving DC to the site of the granuloma supports the premise that one role of the DC is to 
serve as a key initiator of a type 1 immune response (54).  
 The fascin+ cells and the fascin mRNA+ cells were abundant in the granulomatous lesion 
(Fig. 9F-H), which are most likely DC. Previous studies have shown that fascin is present in the 
cell body and dendritic portions of cultured Langerhans cells and the expression of fascin 
increased in concordance with the maturation of the DC (156,157). Fascin can also be expressed 
by fibroblasts (158) and neuronal cells (156). Although we cannot definitively state that these 
fascin+ cells are DC, the morphological structure of these cells does correlate with DC and less 
so with the fibrin-like structure of fibroblasts encircling the granuloma. 
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  Previously, we have shown that DC-LAMP mRNA expression is present in cells lining 
the alveolar walls, consisting of approximately 10-15% of the total cells (139). We have also 
shown previously that DC-LAMP mRNA was abundant in the lymphoid tissue, distributed 
distinctly from the DC-SIGN mRNA signal (72). Other groups have recently shown that type II 
pneumocytes also express DC-LAMP in association with the MHC class II molecule, suggesting 
a similar function in both cell types (140,141). In the macaque tissues examined here we found 
that DC-LAMP co-localizes with surfactant B, which is a type II pneumocyte marker in the lungs 
(Fig. 11D). This suggests that the DC-LAMP mRNA we observed in macaque lung tissues and 
surrounding the granulomatous lesions are likely type II pneumocytes and not DC. While the 
appearance of DC-LAMP mRNA+ cells inside the granuloma is suggestive that mature DC are 
present within the granuloma, our data also suggest that these are actually type II pneumocytes 
that became trapped upon the influx of immune cells into the inflammatory site and eventually 
are completely encased in the growing granuloma.  
IFN-γ can stimulate DC to recruit and further activate IFN-γ-producing T cell responses 
important for cell-meditated immunity (159), whereas the induction of the immune response by 
IL-4 supports humoral immunity. IL-4 is recognized as a major cytokine in the type 2 immune 
response, which also inhibits IFN-γ production of type 1 responses. Standard differentiation of 
DC ex vivo utilizes IL-4 in combination with GM-CSF. GM-CSF supports the survival and 
proliferation of the DC progenitor, whereas IL-4 contributes to myeloid cell maturation. 
Interestingly, treatment of maturing DC with IL-4 increases the production of DC-STAMP (152). 
I observed that DC-STAMP mRNA was localized to the cellular/acellular border of the caseous 
granuloma (Fig. 11E), but I was unable to detect IL-4 mRNA by ISH (60). Interestingly, 
monocytes (153) and B cells (Fig. 14) also express DC-STAMP/FIND upon IL-4 stimulation, 
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 suggesting that DC-STAMP/FIND could be used as a surrogate marker for local IL-4 production. 
IL-4 treatment of monocytes has illustrated a potential mechanism for an amplification loop of 
polarized Th2 responses (160) and IL-4 treatment also mediates the induction of IL-12p70 in 
human Th2 cells (161), which could serve to balance type 2 and type 1 responses. By real-time 
RT-PCR we clearly showed that IL-4, not IL-15, induced DC-STAMP in monocyte-derived DC 
(Fig. 14) and IL-4 induced DC-STAMP expression in B cells (Table 6). Whether IL-4 is 
contributing to a deactivation of the type 1 immune response in these tissues is still unclear, but 
treatment of maturing DC with IL-4 has shown a reduced responsiveness to CD40 stimulation 
(162) and CD40L treatment revealed a 10-fold decrease in DC-STAMP expression (152). DC-
STAMP/FIND is a protein with an N-terminal signal anchor of 52 amino acids, seven 
transmembrane regions, one intracellular loop and two extracellular loops, which have three 
putative N-glycosylation sites, and a cytoplasmic C-terminus (153). This putative protein also 
contains several potential myristoylation and phosphorylation sites, a phospholipase A2 site and 
a G-protein β WD-40 repeat, a 40-residue domain containing a characteristic Trp-Asp motif 
(genome.ucsc.edu). The G protein β subunits do not have a clearly defined function, but seem to 
be required for the replacement of GDP by GTP and in membrane anchoring and receptor 
recognition (163). All of these findings suggest that DC-STAMP/FIND may be enhanced due to 
a type 2 cytokine and potentially could function as a receptor subunit to downregulate the type 1 
immune response locally. 
 Mathematic modeling of M. tuberculosis infection suggests that DC are necessary for the 
development of protective immunity against M. tuberculosis (164) and are likely involved in the 
control of the granuloma, possibly by aiding in granuloma formation. DC-recruiting chemokines 
have been observed in granulomas of giant cell arteritis and potentially are responsible for the 
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 continual presence of DC at the site of inflammation (58), and we have observed that tuberculous 
granulomas also have cells expressing CCL19/MIP-3β and CCL21/6Ckine mRNA  (Fig. 12) and 
numerous dendritic cell markers (Fig. 9  and 11). The most convincing data within these studies 
are the fascin+ cells by ISH and IHC illustrating the abundance and distribution of the DC within 
granulomatous structures. It is true that the DC play a major role in the establishment of the 
immune response and that a rapid DC turnover at the site of infection combined with a strong 
activation of DC will lead to a minimal antigen presentation and lead to the production of 
cytokines responsible for a protective response.  
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V. 
FINAL DISCUSSION  
 
Tuberculosis is a worldwide epidemic that is continually causing deaths and is a major 
AIDS-related complication. Although a large amount of research has attempted to elucidate ways 
to understand, control and prevent M. tuberculosis infection, the processes of disease are not well 
understood. Tuberculosis is characterized by a predominant type I immune response, which has 
high levels of IFN-γ and proinflammatory cytokines. The objective of this body of work was to 
define the potential roles of IFN-γ-inducible chemokines and proinflammatory cytokines in the 
granulomatous tissues of cynomolgus macaques infected with M. tuberculosis, while examining 
the putative roles of DC in these processes. We have utilized single-cell based techniques to 
analyze the expression of chemokine and proinflammatory cytokine mRNAs and to determine 
what cell types are expressing these mRNAs. In addition, we also have utilized these single-cell 
based assays to examine the expression of DC-associated transcripts in an attempt to define the 
DC populations present within the granulomatous structure. Since CXCR3 ligands can be 
induced by IFN-γ stimulation of DC, we also examined the ability of DC to express these 
CXCR3 ligands and whether DC are the major producer of the abundant CXCR3 ligand 
expression.  
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 Abundant IFN-γ-inducible chemokine expression 
In these studies, we determined that the granulomas are the site of an abundant 
expression of IFN-γ-inducible chemokines and proinflammatory cytokines. Other cytokines 
consistent with IFN-γ expression, or a type I immune response (such as CCR5 ligands), were 
also observed. Whereas macrophages and lymphocytes were the predominant cells within 
granulomatous tissues, we did observe a considerable number of B cells and DC within the 
granulomatous structure. We also observed a large number of DC-associated transcripts, which 
are associated with different maturation and activation states. Although DC were capable of 
producing CXCR3 ligands upon IFN-γ stimulation in vitro, the majority of CXCR3 ligand 
mRNAs associated with the granuloma were expressed by CD68+ macrophages rather than by 
fascin+ DC (Fig. 9).  
The CXCR3 ligands are IFN-γ-inducible chemokines, which are observed in type I 
immune responses and CXCL10/IP-10 can be upregulated upon innate activation, such as 
through Toll-like receptors (TLRs). IFN-γ-inducible chemokines were abundant in granulomas 
and the expression level of CXCR3 ligand was proportional to the granuloma size, but the signal 
intensity of each chemokine was relatively similar when the signal intensity/cellular area of solid 
granulomas was compared to caseous granulomas. Although no direct association was shown 
between the number of IFN-γ mRNA+ cells and/or TNF-α mRNA+ cells with increasing amounts 
of CXCR3 ligand mRNA expression, this is likely due to the fact that the granuloma sections we 
observed were 14µm sections of a much larger three-dimensional histological structure in the  
lung. If we had observed mRNA expression profiles from a disaggregated granuloma, we likely 
would be able to measure a potential association more accurately. The number of IFN-γ mRNA+ 
and TNF-α mRNA+ cells were approximately three times more numerous in the caseous 
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 granulomas than in the solid granulomas (Table 3), and the average size of the caseous 
granulomas were also approximately three times the size of the solid granulomas. This 
potentially explains the three-fold difference in the cytokine mRNA, which appears in a 
dispersed pattern, and the same thresholded values obtained via quantitative image analysis of 
chemokine mRNA, which are extremely abundant. 
The IFN-γ-inducible chemokines have been shown to inhibit bone marrow colony 
formation (165), possess antitumor activity in vivo (166-168), promote T cell adhesion to 
endothelial cells (169,170), and inhibit angiogenesis (171,172). The increased expression of 
angiogenic molecules, such as vascular endothelial growth factor (VEGF) is significantly 
correlated with active pulmonary tuberculosis (84,173,174). Thus, the abundance of IFN-γ-
inducible chemokines recruit immune cells to aid in the immune response, but also work to 
counterregulate inflammatory events, such as neovascularization. Interestingly, Cole et al., have 
shown that IFN-γ-inducible chemokines have defensin-like antimicrobial activity against 
Escherichia coli and Listeria monocytogenes (175). These studies also showed that the 
concentration of IFN-γ-stimulated chemokines produced by PBMC was sufficient for 
antimicrobial activity suggesting that the IFN-γ-inducible chemokines may inhibit certain 
microbes in addition to the recruitment of immune cells to the site of inflammation (175).  To 
this end, IFN-γ-inducible chemokines could also be antimycobacterial.  
Additionally, the CXCR3 ligands are antagonists for CCR3, which is characteristically 
expressed by Th2 lymphocytes, thereby inhibiting the migration of CCR3+ cells toward ligands, 
such as CCL11/eotaxin-1, though without causing internalization of CCR3 (176). Therefore, 
chemokines that attract Th1 cells via CXCR3 can concomitantly block the migration of Th2 cells 
in response to CCR3 ligands, thus further enhancing the polarization of the local environment. 
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 CXCL11/I-TAC also has an additional interesting characteristic potentially relevant to 
tuberculosis and granuloma formation. CXCL11/I-TAC also binds to CCR5 and blocks 
migration of CCR5+ cells, as well as inhibits the release of intracellular calcium and actin 
polymerization by CCR5 ligands (177).  Thus, CXCL11/I-TAC likely has a different set of 
overlapping functions relative to CXCL9/Mig and CXCL10/IP-10. Although CXCL11/I-TAC 
has a higher binding affinity for CXCR3 compared to CXCL9/Mig and CXCL10/IP-10 (178), 
competitive binding studies have revealed that these IFN-γ-inducible chemokines are allotropic, 
or noncompetitive, ligands for CXCR3 (179). In addition to these studies, CXCL11/I-TAC-
induced internalization of surface CXCR3 was significantly increased compared to the other two 
CXCR3 ligands (97) and CXCL11/I-TAC used a distinct domain in the CXCR3 molecule 
compared to CXCL9/Mig and CXCL10/IP-10 (180).  These findings suggest that the differential 
requirement of these domains contributes to the complexity of the chemokine system and further 
suggest that true chemokine redundancy may not be operative in vivo. 
 
Type 1 amplification loop 
The identification of abundant expression of the IFN-γ-inducible chemokines and the 
proinflammatory cytokines directly in the granulomatous lesion is a novel observation. In 
addition, we also sought to determine the cell types expressing these immune molecules. 
Simultaneous ISH and IHC revealed that the CXCR3 ligands were produced most predominantly 
by CD68+ macrophages, to a lesser extent by fascin+ DC, and not by CD20+ B cells (Fig. 10). 
Although previous studies have shown that macrophages, DC and B cells are all capable of 
producing CXCR3 ligands upon IFN-γ stimulation (96,181), we determined that the major 
producers of the IFN-γ−inducible chemokines in the granulomatous lesions were macrophages. 
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 This is not unexpected since the predominant cell types in the granuloma are macrophages and T 
lymphocytes (164). Induction by the large amount of IFN-γ in the granulomatous lesion and the 
fact that macrophages can produce CXCR3 ligands upon M. tuberculosis infection (34) likely 
explains the massive expression of CXCR3 ligands in the granuloma. In a type 1-mediated 
pulmonary disease, the local expression of IFN-γ-inducible chemokines likely induces the 
trafficking of effector T cells and monocytes to the inflammatory site within the lung tissues, 
which leads to a local chronic inflammation in the lungs. This influx of activated type 1 immune 
cells further enhances the IFN-γ production and further amplifies this process producing an IFN-
γ-driven positive feedback mechanism (Fig. 15). This amplification loop of chemokine 
production/IFN-γ-producing cell recruitment has been previously discussed in the context of SIV 
(68) and may represent the same amplification processes seen in tuberculosis and possibly in 
other type 1 diseases. Whereas the increased recruitment of IFN-γ-producing cell recruitment is 
important in the immune response to tuberculosis, an uncontrolled amplification loop potentially 
can lead to more devastating outcomes, such as tissue destruction. 
 
Potential chemokine-altering molecules 
The CXCR3 ligands recruit CXCR3+ cells, which are predominantly activated IFN-γ-
producing T cells (93,96,175,182,183). This massive expression of type 1 recruiting molecules 
further amplifies the recruitment signal into the inflammatory site. Although we studied the 
expression levels at the mRNA level, it was not determined whether or not the respective 
proteins were expressed or were functional. Multiple attempts in our laboratory to stain for 
CXCL9/Mig protein in tissue sections has not yielded conclusive results. Molecules such as 
CD26 or matrix metalloproteinases (MMPs) have the ability to counterregulate chemokine 
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Figure 15. Proposed model for type 1 amplification loop in tuberculosis. Infected macrophages 
secrete chemokines, which attract IFN-γ-producing lymphocytes. The increased expression of 
IFN-γ leads to an increased production of CXCL9/Mig, CXCL10/IP-10 and CXCL11/I-TAC. 
The increased expression of the CXCR3 ligands recruits more IFN-γ-producing CXCR3+ cells, 
which further upregulate the expression level of CXCR3 ligands. In addition, CXCR3 ligands 
also negatively impact the recruitment of CCR3+ cells. The increased recruitment of CXCR3+ 
cells is associated with CD26 expression, which proteolytically cleaves CXCR3 ligands and 
converts them into CXCR3 antagonists. 
 
 
 
function. CD26 is a dipeptidyl peptidase that cleaves behind the proline residue at the 
penultimate N-terminal amino acid position, altering the efficiency of chemotactic recruitment of 
a subset of chemokines (184). CD26 cleaves multiple chemokines, affecting their chemotactic 
potential differently, and has been shown to reduce the chemotactic potential of CXCL9/Mig, 
CXCL10/IP-10 and CXCL11/I-TAC (110). Preliminary studies performed in our laboratory have 
shown an abundant expression of CD26 mRNA associated with granulomatous tissues compared 
to normal lung tissues (data not shown).  Interestingly, when the first two  N-terminal amino 
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 acids are truncated, CXCL11/I-TAC becomes a potent antagonist for CXCR3 (110). Therefore, 
N-terminal truncation is a potential feedback mechanism to help control the amplification loop 
that may develop in a recruitment schematic similar to this type I-dominated immune response. 
Another chemokine-altering group of molecules is the family of MMPs, which are 
associated with extracellular matrix degradation and enzyme processing of bioactive molecules. 
Gelatinase A (MMP2) and B (MMP9) have been shown to cleave multiple CC- and CXC-
chemokines with varying effects. Gelatinase B/MMP9 cleaves ELR+ (Glutamic acid-Leucine-
Arginine) CXC-chemokines in the amino terminus, but MMP9 has been shown to degrade 
CXCL10/IP-10 and cleave CXCL9/Mig at three locations in the carboxyterminus (185), neither 
of which are ELR+ chemokines. Whereas basic residues at the carboxyterminal end of 
CXCL10/IP-10 are essential for the binding of CXCL10/IP-10 to CXCR3, these residues are less 
important for the binding to negatively charged polysaccharides (186). The carboxyterminal 
truncation of CXCL9/Mig greatly decreased its biological activity (181,187) and its ability to be 
immobilized through binding to extracellular matrix polysaccharides, which is a component of 
the chemotactic gradient (181). Thus, the MMPs, which are abundantly expressed in 
inflammatory tissues by the infiltrating cells, may be able to diminish or abolish the chemotactic 
potential of the CXCR3 ligands within these granulomatous lesions.  
 
Expression of CCL5/RANTES, CCL3/MIP-1α, and CCL4/MIP-1β mRNAs in granulomas 
Activated type 1 cells and macrophages are recruited to the site of inflammation through 
the receptor CCR5 (93). The CCR5 ligands, CCL5/RANTES, CCL3/MIP-1α, and CCL4/MIP-
1β, were also expressed in the granulomatous tissues studied here, as determined by ISH (Fig. 8). 
The CCR5 ligands were concentrated within the granulomatous structures, although not to the 
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 same levels as the CXCR3 ligands, whereas the CCR5 ligand mRNAs were virtually absent in 
the nongranulomatous regions of lung tissue. The increased expression of these chemokines, in 
addition to the abundant CXCR3 ligand expression, further suggests an overwhelming 
recruitment of immune cells capable of producing type 1 or pro-inflammatory cytokines, 
including activated Th1 cells, cytotoxic T cells, macrophages and DC. These findings further 
support the notion that the granulomatous environment contains numerous signals directing the 
recruitment of type 1 immune cells that are capable of producing IFN-γ, which can lead to 
further upregulation of CXCR3 ligands or to antimycobacterial actions by macrophages. 
 
Potential inhibition of DC by Interleukin 6 
Another important cytokine in the inflammatory process is IL-6. IL-6 has systemic and 
local properties that include activation of acute phase proteins, recruitment of neutrophils to 
inflammatory sites, activation of lymphocytes, and induction of fever. The differentiation of B 
cells into plasma cells and the differentiation of naïve T cells into Th2 cells are also activities 
attributed to IL-6 (188). We have observed IL-6 mRNA as abundantly expressed within 
pulmonary granulomas (Fig. 13) and previous studies have shown that IL-6 secreted from M. 
tuberculosis-infected macrophages has inhibited a subset of IFN-γ-responsive genes, including 
IFN-γ-inducible class II trans-activator (CIITA), CXCL9/Mig and IFN regulatory factor (IRF)-1 
(151). Although previous studies have shown an increased expression of IL-6 upon M. 
tuberculosis or BCG infection of DC (85,86,189,190), no reports have shown the effects of IL-6 
on DC responsiveness to IFN-γ.  We examined monocyte-derived DC for their ability to produce 
IFN-γ-inducible chemokines upon M. tuberculosis infection and in the presence of IFN-γ or IFN-
γ plus IL-6. We found that IL-6 during M. tuberculosis infection reduced CXCL9/Mig and 
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 CXCL10/IP-10 expression (Table 7). Whereas this reduction of CXCL9/Mig (1.5 fold reduction) 
is similar to the studies in macrophages performed by Nagabhushanam et al., DC may not be as 
responsive to IL-6 as macrophages. CXCL10/IP-10 was not significantly different in the 
previous study. The ability of IL-6 to inhibit IFN-γ-induced genes may also contribute to the 
host’s inability to mount an appropriate cellular immune response sufficiently to eradicate 
infection. Reduction of other IFN-inducible genes may have a detrimental effect on the overall 
immune response.  For example, the reduction of IRF-1 by IL-6 would lead to TNF-α-mediated 
activation of MMP-9 (191), which cleaves the carboxyterminus of CXCR3 ligands, as mentioned 
above, ultimately reducing the ability of CXCR3-ligands to bind to the extracellular matrix and 
form a chemotactic gradient.  
 
Early granulomatous structures 
Although many studies have attempted to elucidate the molecules responsible for the 
maintenance of a granuloma, we wanted to examine pulmonary tissues of M. tuberculosis-
infected macaques for early stages of granuloma formation. Eight cynomolgus macaques were 
infected with M. tuberculosis Erdman strain and were sacrificed at weeks 3, 4, 5 or 6 p.i. The 
hilar lymph nodes and three lobes of the lung were analyzed for early granulomas (or 
pregranulomas) by hematoxylin/eosin (H/E) staining and ISH for mycobacterial 16S rRNA and 
CXCL10/IP-10 mRNA on 14µm sections every 280µm over a total of 2,800µm of lung tissue. 
We used these markers to examine the lung tissues for potential accumulations of either 
mycobacterial rRNA or chemokine mRNA, as an indicator of potential pregranulomatous 
structures. Unfortunately, we did not observe any pregranulomatous structures, but we did 
observe a caseous granuloma in the right lower lobe of M21902 and in the left hilar lymph node 
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 of M24102 (both of which were sacrificed at 5wk post-infection). Whereas the ISH studies on 
these granulomas were concordant with our previous findings (Fig. 2, Table 3), there was an 
abundance of mycobacterial 16S rRNA within the granuloma from the lymph node compared to 
the pulmonary granuloma. In addition, the granuloma within the hilar lymph node had slightly 
higher CXCL10/IP-10 compared to CXCL9/Mig (Fig. 7). This was in contrast to our previous 
findings that CXCL9/Mig was the most abundant IFN-γ-inducible chemokine in more developed 
granulomas. This higher expression level of CXCL10/IP-10 was consistent with murine studies 
performed in which CXCL10/IP-10 was observed as early as 3 days p.i. and CXCL9/Mig was 
not observed until 6 days p.i. and only in a proportion of mice (87). In addition, Algood et al., 
also examined the effect of anti-TNF treatment on chemokine expression (87). The anti-TNF 
treatment caused a reduction in the expression of the two CXCR3 ligands further suggesting that 
TNF-α may have an inductive effect on local chemokine expression prior to granuloma 
formation.  
 
Dendritic cell-associated studies 
The studies described in Chapter IV have expanded the current knowledge of the 
populations of DC within the granuloma. Previous studies have suggested that DC in the lung 
tissues are immature in function, but we were not able to detect the immature DC marker, DC-
SIGN. The expression level of DC-SIGN on immature DC in the lung may have been below the 
level of sensitivity of the assay, but this is unlikely since we were capable of detecting DC-SIGN 
in hilar lymph node and spleen of these macaques by ISH. Interestingly, DC-LAMP mRNA was 
abundantly expressed in and around the granulomatous structure, and we have previously shown 
that approximately 10% of the cells in rhesus macaque lung tissues express DC-LAMP mRNA 
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 (139). This initially led us to believe that mature DC were extremely abundant and possibly 
forming a protective “surveillance” barrier around the granuloma. However, two recent studies 
(140,141) and our ISH studies for surfactant B mRNA (Fig. 11) have revealed that the DC-
LAMP+ cells in the lung tissues are actually type II pneumocytes. This contradicts our theory of 
DC forming a barrier around the granuloma, and brings into question why type II pneumocytes 
are so abundant around and within the cellular region of the granuloma. The most logical reason 
is that the granuloma forms and begins to expand into the lung alveoli and the type II 
pneumocytes become trapped on the inside and outside of the granulomatous structure.  
Mature DC have been shown to preferentially express CCR7 (94) and we found the ISH 
signal for CCR7 mRNA concentrated within regions of the granuloma (Fig. 11), as was ISH 
signal for CCR7 ligands within the same regions (Fig. 12), suggesting that mature DC could be 
present within the cellular region. This is consistent with our fascin immunohistochemical 
staining and ISH findings (Fig. 9). Interestingly, B7-DC was abundantly expressed within the 
granuloma and this expression of B7-DC could play either a costimulatory or inhibitory role. 
Initial studies have not clarified whether B7-DC inhibits the stimulation of T cells by binding to 
the inhibitory receptor, programmed death (PD)-1 (192), or whether B7-DC costimulates T cell 
proliferation and cytokine production, such as IFN-γ (132). Previous studies have shown that 
cross-linking B7-DC with a naturally occurring antibody directly activated immune function in 
the DC (193), but recent studies have revealed that antibody binding of B7-DC augments T cell 
stimulation and results in the inhibition of a negative signal (194). PD-1 is a known inhibitory 
receptor of T cells (131) and B cells (195), and Chemnitz et al., have shown that inhibition of T 
cell activation occurred with the apparent colocalization of PD-1 with CD3 and/or CD28 (196). 
Their data suggest that the T cell stimulation observed in the B7-DC studies was due to the 
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 suboptimal levels of anti-CD3 used (132). This inhibitory action on T cell activation could be a 
further regulation of the immune response to prevent T cell anergy or T cell exhaustion. 
 
Development of mycobacterial 16S rRNA ISH assay 
Acid-fast staining is routinely used in laboratories to identify the presence of acid-fast 
bacilli (AFB) organisms in the sputum, BAL, and pleural effusions, but our initial efforts to stain 
for AFB in paraformaldehyde-fixed tissues had little success even though the lesions seemed 
histologically active. Previously, Fukunaga et al., revealed that formalin and xylene greatly 
reduced the sensitivity of acid-fast staining and the numbers of bacilli estimated by real-time 
PCR were considerably higher than those counted manually with a microscope. These results 
suggest that the bacilli are frequently missed or underestimated with acid-fast microscopy on 
formalin-fixed, paraffin-embedded tissue (111). In an attempt to increase the sensitivity of M. 
tuberculosis detection in our paraformaldehyde-fixed tissue sections, I developed an ISH assay, 
which detected mycobacterial 16S rRNA, alpha-crystallin (hspX) and RNA polymerase beta 
subunit (rpoB). We did not detect hspX mRNA, which is a surrogate marker for latent infections 
(197), or rpoB mRNA, which is expressed during active replication (198), but we did detect 
mycobacterial 16S rRNA in granulomatous tissues. Although this 16S rRNA assay will also 
detect other mycobacterial 16S rRNA due to high levels of sequence similarity, lung tissue 
sections from uninfected controls and from nongranulomatous tissues had no detectable ISH 
signal for mycobacterial 16S rRNA. This is in contrast to the intense focal collections of silver 
grains observed in many granulomas observed in the lungs of cynomolgus macaques infected 
with M. tuberculosis. The main limitation of this assay is the possibility that this assay may also 
detect extracellular mycobacterial rRNA or dead mycobacteria, although it needs to be noted that 
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 these nonviable mycobacterial components likely still have very potent biological activity. Even 
though this limitation exists, it is likely that the immune cells are recruited to the granulomatous 
lesion in an attempt to control the infection or remove the antigenic stimulation. Therefore, the 
assay described in this dissertation overcomes the limitations of certain fixation protocols and 
provides an increased level of specificity due to the RNA:RNA hybrids within the ISH assay. 
 
Type 2 immune response in granulomatous lesions 
In addition to examining type 1-associated chemokines, we also examined the expression 
of CCL2/monocyte chemotactic protein (MCP)-1, which is a chemokine regulated by Th2 
cytokines, IL-4 and IL-13. Interestingly, CCL2/MCP-1 can stimulate IL-4 production and 
CCL2/MCP-1 overexpression is associated with defects in cell-mediated immunity (199-202). 
Although not strictly a “type 2 chemokine”, these data are consistent with a potential role for 
CCL2/MCP-1 in type 2 processes. In the left hilar lymph node of a 5 wk post-infection 
cynomolgus macaque (M24102), a granuloma was observed in the hilar lymph node that 
expressed CCL2/MCP-1 mRNA, which had a higher signal intensity than CCL5/RANTES. The 
mRNA signal consistently was surrounding the perimeter of the caseous granuloma (Fig. 8). This 
particular granuloma also had high expression levels of CXCL9/Mig, CXCL10/IP-10, IFN-γ and 
TNF-α mRNAs in the cellular portion in addition to an abundant level of mycobacterial 16S 
rRNA within the central (acellular) portion of the granuloma (Fig. 7). Although it is unclear what 
role CCL2/MCP-1 may play during this early timepoint, it is interesting that we observed both 
type 1 cytokines and chemokines and a potentially type 2 chemokine present at such an early 
stage of the infection. This illustrates an early time in the immune response showing that IFN-γ 
and other type 1 molecules can be abundantly present early after infection, thereby contributing 
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 to a predominant type 1 immune response. However, our study did not resolve whether IL-4 
might have acted in a protective role in mycobacterial infection, as seen in conflicting reports in 
IL-4 knock-out mice (203,204), but does raise the question of the presence of these IL-4-
inducible molecules and what potential function these molecules may have. 
 
Putative model of DC-STAMP/FIND involvement in tuberculous granuloma 
Interleukin-4-induced expression of DC-STAMP/FIND was initially described 
concurrently by two different groups studying DC and macrophages, respectively (152,153). In 
addition, my studies revealed that DC-STAMP/FIND expression was observed by real-time RT-
PCR in DC and B cells derived or stimulated with IL-4 (Fig. 14) and DC-STAMP/FIND mRNA 
was exquisitely localized to the interface between the cellular and acellular portions of caseous 
granulomas (Figure 11E). It should be noted that thus far IL-4 is the only cytokine demonstrated 
to induce expression of DC-STAMP/FIND.  IL-10 (153) and IL-15 (Table 6, Fig. 14) do not 
induce DC-STAMP/FIND expression.  We did not detect IL-4 mRNA in any of the macaque 
tissues, but the level of IL-4 expression may have been below the level of detection in our assay. 
Frequently, IL-4 protein can not be detected by ELISA due to the very low concentrations and 
only the effects of IL-4-neutralizing antibodies are assessed (205). In addition, IL-4 has a low 
mRNA copy number and IL-4 mRNA has a short half-life (206,207), suggesting that detection of 
IL-4 mRNA would be extremely difficult without the immediate use of an mRNA stabilizing 
buffer. In fact, only one group has been able to detect IL-4 mRNA in granulomatous tissues 
(27,208,209) and conclusions from their findings suggest that IL-4 may be involved in reducing 
the amount of tissue damage by acting as an anti-inflammatory molecule at the local site.  
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 Interestingly, CD1d-restricted T cells (NKT cells) are innate memory cells activated by 
glycolipid antigen and play important roles in the initiation and regulation of the immune 
response and secrete large quantities of cytokines, including IL-4 as well as IFN-γ (210). NKT 
cells can influence various immune responses, including tumor rejection, the maintenance of 
self-tolerance, autoimmunity and the response to infectious agents (210). Although pulmonary 
granulomatous lesions are not significantly different in NKT knock-out mice compared to wild-
type (211) and Vα14 NKT cells contribute only minimally to the Th1 immune response in 
murine mycobacterial infections (212), NKT cells play a potential role in late-phase 
mycobacterial infections (211) and express granulysin in a CD1d-dependent manner, thereby 
restricting the intracellular growth of M. tuberculosis (213). Additionally, NKT cells express 
high levels of CXCR3 and CCR5 and have chemotaxis patterns similar to Th1 inflammatory 
homing cells, suggesting that the CD1d-restricted NKT cells perform their specialized function 
in peripheral tissue sites rather than in secondary lymphoid organs (214,215). The abundant 
expression of CXCR3 ligands, which I have demonstrated, could therefore recruit NKT cells to 
these inflammatory environments. If we extrapolate from the DC-STAMP ISH data that IL-4 is 
expressed in the internal portion of the granuloma, in concert or separately from IFN-γ 
production, potentially by NKT cells responding to M. tuberculosis in a CD1d-dependent 
manner, we can develop a preliminary model for the involvement of DC-STAMP/FIND and IL-4 
in this type 1-biased chronic inflammatory environment (Fig. 16). This model was developed 
based on some of my preliminary data and previous studies showing an abundance of IFN-γ-
inducible chemokine mRNAs, putative recruitment of IFN-γ-producing CXCR3+ cells and 
expression of DC-STAMP/FIND mRNA. As cells are recruited to the granulomatous site by 
chemokines, CXCR3+ cells are recruited, including Th1 cell, CD8+ and TCRγδ T cells and NKT 
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Figure 16. Schematic model of IFN-γ-inducible chemokines and DC-STAMP/FIND in the 
context of M. tuberculosis infection. An infected macrophage secretes chemokines that recruit 
many cell types including monocytes (yellow) and lymphocytes (T, green; B, brown). The 
increased presence of macrophages and lymphocytes produce IFN-γ in response to mycobacterial 
antigen. IFN-γ-induces macrophages to produce IFN-γ-inducible chemokines (pink circles), 
which in turn recruit more CXCR3+ cells, including more lymphocytes and macrophages. As the 
granulomatous lesion grows, the central acellular region becomes less accessible to the external 
cellular components. This induces a reduced IFN-γ environment on the internal portion of the 
granuloma, causing a less controlled environment. Increased IL-4 centrally induces the increased 
expression of DC-STAMP/FIND (aqua) expressed along that acellular/cellular border. 
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 cells. Although the main cytokine produced by these cells is IFN-γ, the possible expression of 
IL-4 by NKT cells could drive the expression of DC-STAMP/FIND. Additionally, previous 
studies in mice have shown an increased Th2 switch in tuberculosis. Whereas IL-4 was not 
detected in lymphocytes and macrophages treated with live mycobacteria, IL-4 was detected in 
lymphocytes treated with dead mycobacteria and hsp60 (216). This could be an indication of 
what we observed in the caseous granulomas. If the cellular debris within the caseous 
granulomas contains dead mycobacteria, then it is quite likely that the CD4+ lymphocytes will 
produce IL-4, as previously reported (216). Since the function of DC-STAMP/FIND has not 
been elucidated, it is still unclear whether the expression of DC-STAMP/FIND will serve as a 
surrogate marker of IL-4 expression alone or will also negatively regulate the IFN-γ-dominated 
immune response and lead to disease progression or provide a function not currently understood. 
The studies described in this dissertation provide additional information on the 
chemokine profile within the granulomatous lesions. The CXCR3 ligands are abundantly 
expressed, and likely in concert with CCR5 ligands, are providing a constant recruiting 
mechanism to continuously replenish the antigen-specific response directed against the 
microorganism present inside the granuloma. Although we did not directly show the recruitment 
of CXCR3+ cells into the granuloma, we have shown that there is a definitive difference in the 
absence of CXCR3+ cells in uninfected lungs correlating with the absence of CXCR3 recruiting 
molecules. Additionally, we have not directly shown that the CXCR3 ligands, instead of other 
factors, are actively recruiting these CXCR3+ cells to the site of inflammation. We have 
definitely shown that the level of expression is massive and the growth of these granulomas 
potentially could be occurring due to uncontrolled mechanisms. These studies are relevant for 
therapeutic treatment studies, and complete blocking of CXCR3 might prevent further growth of 
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 the granuloma, but this type of therapy would likely be devastating. The potential outcomes 
would be (1) the partial inhibition of the growth of the granuloma, if at all, or (2) destruction of 
the granuloma, similar to the anti-TNFα treatment studies (217,218), which would likely lead to 
the progression of disease. 
In summary, these studies have shown that the IFN-γ-inducible chemokines, IFN-γ and 
TNF-α are abundantly expressed within the granulomatous lesions and are likely involved in the 
recruitment of the CXCR3-bearing cells to the inflammatory site. In addition, myeloid DC are 
present within the granulomatous structure. In vitro, myeloid DC are capable of producing high 
levels of IFN-γ-inducible chemokines, but macrophages are responsible for the abundant 
upregulation of the IFN-γ-inducible chemokines within these granulomatous tissues. In addition, 
this is the first report of the expression of an IL-4-inducible transmembrane molecule associated 
with a tuberculous granuloma. Even though the function of DC-STAMP/FIND is unknown, we 
believe that its expression can be used as a surrogate marker for IL-4 expression. All of these 
studies further expand the current knowledge about tuberculosis and the immune response 
induced during infection. In conclusion, tuberculosis is a chronic inflammatory disease that is 
characterized by a type 1 amplification process of chemokine/cytokine interactions and the host 
mechanisms, which counterregulate these processes do not appear to diminish the amplification 
processes observed in these studies. 
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VI. 
FUTURE DIRECTIONS 
 
While this dissertation has addressed a number of aspects pertaining to the potential roles 
of the IFN-γ-inducible chemokines in the maintenance of the pulmonary granuloma, many 
questions and alternative directions have arisen through the course of these studies. The 
following section discusses several questions that remain unresolved and if addressed, could 
offer valuable information regarding granuloma structure and/or DC biology. 
 
Determine potential synergistic effects of CXCR3 and CCR5. I have exhaustively 
examined the expression of IFN-γ-inducible chemokines in the granulomatous structure, but only 
a preliminary examination of all three CCR5 ligand expression patterns was performed. Since 
activated Th1 lymphocytes commonly express both CXCR3 and CCR5 (93), examination of 
granulomatous lesions for the expression of CCR5 mRNAs could be done to determine if CCR5 
is affected by M. tuberculosis infection. In addition, in vitro chemotaxis assays would clarify any 
potential synergistic effects of CXCR3 and CCR5 ligands and whether chemokines work in a 
coordinated manner to recruit type 1 lymphocytes capable of producing IFN-γ. Since CXCL11/I-
TAC acts as an antagonist of monocyte recruitment through CCR5, we would investigate 
whether CXCL11/I-TAC acts in a similar manner on CCR5+ lymphocyte population as well. 
Further investigation into the putative role of CXCL11/I-TAC will elicit information on the 
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 increasing data that CXCR3 ligands are not merely redundant, but all serve a purported function. 
These additional studies could further define the interplay between CXCR3 and CCR5 ligands in 
the recruitment of immune cells to the site of granulomatous lesions within the pulmonary cavity 
during tuberculosis. 
 
Establish an in vitro model system of granulomas. We have performed tissue-based 
and in vitro approaches in this dissertation, but these assays lack the ability to discern three-
dimensional growth and maintenance of the granulomatous structure. Previously, many studies 
have used standard cell culture and chemotaxis assays to answer questions regarding the 
development of a chemotactic gradient and/or the migration of cells, but none of these assays 
have the potential to accurately mimic the formation of granuloma formation and maintenance 
that occurs in vivo. We have attempted to find pregranlomatous tissues in infected monkeys, but 
were unsuccessful. Thus, the establishment of a 3-dimensional cell culture model would 
potentially allow us to examine the formation of a granuloma, while preserving the cell-cell and 
cell-environment interactions observed in vivo. Three-dimensional cell cultures using varying 
forms of collagen-lattice networks have been used, including BD Matrigel matrix (Becton 
Dickinson), which has been used to study cell morphology, biochemical function, migration or 
invasion, and gene expression. This type of system consists of extracts from solublized basement 
membrane preparations extracted from an extracellular matrix (ECM) rich murine sarcoma, 
which resembles the mammalian cellular basement membrane. This system would enable us to 
examine, in vitro, the migration of immune cells to the site of infection and formation of 
granulomas in a three dimensional nature. Although the complexity of a tuberculous granuloma 
likely would never be replicated in vitro, this type of model system likely would provide us with 
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 more information about the early events of granuloma formation, and possibly maintenance of 
granulomas also.  
 
Further examination of DC-STAMP/FIND. I (Chapter IV) and others (152,153) have 
shown that DC-STAMP/FIND is an IL-4-inducible molecule expressed by macrophages, 
dendritic cells and B cells, but the function of DC-STAMP/FIND is still unknown and anti-DC-
STAMP/FIND antibodies have not been successfully produced. 
 
A. DC-STAMP/FIND mRNA expression. We have already observed DC-
STAMP/FIND mRNA in dendritic cells, macrophages and B cells, but it is unclear whether DC-
STAMP/FIND expression is a global marker for IL-4 stimulation. To address this issue, I would 
perform a comprehensive examination of multiple cell types treated with IL-4, in addition to an 
extensive array of other cytokines, to determine if DC-STAMP/FIND mRNA is detectable by 
RT-PCR. These studies will provide more information about the potential target population and 
possibly provide further information about a function of DC-STAMP/FIND. 
 
B. Identify a protein-protein interaction. Previous studies have listed putative 
functional groups on the cytoplasmic domain of DC-STAMP/FIND (152,153), but no follow-up 
studies have been published about the function or potential binding partners. Since DC-
STAMP/FIND has a small extracellular domain, multiple membrane spanning domains and a 
cytoplasmic tail, it is likely that the DC-STAMP/FIND protein may play a role in cell signaling. 
To determine if DC-STAMP/FIND has a binding partner I would utilize the yeast two hybrid 
system to screen a cDNA expression library of dendritic cells in pACT2. Our laboratory has 
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 previously used this methodology to establish the association of simian immunodeficiency virus 
(SIV) with TCRζ chain (219) and we can use this technology to potentially identify a binding 
partner for DC-STAMP/FIND. Although the role of DC-STAMP/FIND is unknown, the 
detection of a binding partner or a protein clearly associated with DC-STAMP/FIND would elicit 
a greater understanding of the potential role of DC-STAMP/FIND. 
As previously stated in this section, these are some of the interesting questions that have 
arisen throughout the course of this project. The completion of these experiments would further 
define the role of chemokines in the recruitment of immune cells to the site of granulomatous 
lesions during maintenance and also would provide a greater understanding of DC-
STAMP/FIND expression and putative function. 
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Table 8. Cynomolgus macaques included in these studies. 
 
 Duration of     Radiographic           
Animal Infection  (wpi)  Readingsa Disease Course  
M12202 3b - early infection necropsy 
M24002 3b - early infection necropsy 
M12302 4b - early infection necropsy 
M24702 4b - early infection necropsy 
M21902 5b - early infection necropsy 
M24102 5b - early infection necropsy 
M24302 6b - early infection necropsy 
M22102 6b - early infection necropsy 
M7100 9b + moderate disease  
M15300 10c +++ advanced disease  
M15000 16b ++ moderate disease  
M14600 17b - no diseased   
M15100 17b + moderate disease  
M12002 19 ++ active/chronic disease 
M11301 32c +++ advanced disease 
M11201 37c +++ advanced disease  
M11501 39 ++ reactivated disease 
M7200 41c +++ advanced disease  
M15200 64b  - minimal disease  
 
aRadiographic readings at necropsy (12). M14600 is the only macaque to not have a positive 
radiographic reading. However, viable M. tuberculosis bacilli could be cultured from lung 
homogenates at necropsy. Results are indicated as follows; -, negative film; +, possibly small 
area of pneumonia, +, positive, ++ and +++, more extensive involvement. 
bSacrificed at a scheduled timepoint. 
cSacrificed due to extreme clinical symptoms. 
dOnly a few macroscopic granulomas were observed at necropsy. 
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